Evaluation of the effectiveness of the national Prevention of Mother-to-Child Transmission (PMTCT) programme on infant HIV measured at six weeks postpartum in South Africa by Goga, Ameena et al.
Evaluation of thE EffEctivEnEss of thE 
national PrEvEntion of MothEr-to-child trans-
Mission (PMtct) 
PrograMME on infant hiv MEasurEd at six WEEks 
PostPartuM in south africa
Medical Research Council, South Africa
School of Public Health, University of the Western Cape,
National Department of Health, South Africa
Centers for Disease Control and Prevention/PEPFAR
National Institute for Communicable Diseases/National Health Laboratory Service
Wits Paediatrics HIV Diagnostics
UNICEF
  
Evaluation of the Effectiveness of the National 
Prevention of Mother-to-Child Transmission 
(PMTCT) Programme at Six Weeks Postpartum 
in South Africa  
2010 
 
        
 
FINAL REPORT 
 
 
Medical Research Council, South Africa 
School of Public Health, University of the Western Cape, 
National Department of Health, South Africa 
Centers for Disease Control and Prevention/PEPFAR 
National Institute for Communicable Diseases/National Health Laboratory 
Service 
Wits Paediatrics HIV Diagnostics 
UNICEF                                                                                        
 
 
 
 
 
 
 
   
Evaluation of the Effectiveness of the national 
Prevention of Mother-to-child transmission 
(PMtct) Programme Measured at six Weeks 
Postpartum in south africa
2010
Medical Research Council, South Africa
School of Public Health, University of the Western Cape,
National Department of Health, South Africa
Centers for Disease Control and Prevention/PEPFAR
National Institute for Communicable Diseases/National Health Laboratory Service
Wits Paediatrics HIV Diagnostics
UNICEF
 ii 
 
Report Prepared by: 
 
Principal Investigators 
Ameena Goga 
Thu-Ha Dinh 
Debra Jackson 
 
SAPMTCTE Study Group 
Yogan Pillay 
Gayle Sherman 
Adrian Puren 
Nonhlanhla Dlamini 
Thabang Mosala 
Siobhan Crowley 
 
Carl Lombard 
Selamawit Woldesenbet 
Vundli Ramokolo 
Wesley Solomon 
Wondwossen Lerebo 
Tanya Doherty 
 
Thurma Goldman 
Jeffrey Klausner 
Katherine Robinson 
 
Nathan Shaffer 
Mickey Chopra 
 iii 
 
Copyright 
Copyright 2012. All material in this report may be reproduced and copied for 
non-commercial purposes: citation as to source, however, is required. 
This report is disseminated by the South African Medical Research Council, National Department of 
Health South Africa and PEPFAR/US Centers for Disease Control & Prevention. 
 
Suggested citation 
Goga AE, Dinh TH, Jackson DJ for the SAPMTCTE study group. Evaluation of the Effectiveness of the 
National Prevention of Mother-to-Child Transmission (PMTCT) Programme Measured at Six Weeks 
Postpartum in South Africa, 2010. South African Medical Research Council, National Department of 
Health of South Africa and PEPFAR/US Centers for Disease Control and Prevention. 2012. 
 
 
ISBN: 978-1-920014-87-2 
 iv 
 
CONTENTS 
PRIMARY CONTACTS/PRINCIPAL INVESTIGATORS…………………………………………………………………………….vii 
ACKNOWLEDGEMENTS…………………………………………………………………………………………………………………….vii 
ABBREVIATIONS AND ACRONYMS…………………………………………………………………………………………………..viii 
EXECUTIVE SUMMARY……………………………………………………………………………………………………………………….x 
Introduction ........................................................................................................................................ x 
Aims and Objectives ........................................................................................................................... x 
Methods.............................................................................................................................................. x 
Results ............................................................................................................................................... xi 
Conclusions and Recommendations .................................................................................................. xi 
FOREWORD BY MINSTER OF HEALTH……………………………………………………………………………………………   xiii 
DEFINITIONS…………………………………………………………………………………………………………………………………… xv 
1. INTRODUCTION               1 
2. METHODOLOGY               4 
2.1 Survey Design and Justification .................................................................................................... 4 
2.2 Study Population and Inclusion/Exclusion Criteria ....................................................................... 5 
2.3 Sampling ....................................................................................................................................... 5 
2.4 Data Collection Tools .................................................................................................................... 6 
2.5 Ethical Considerations .................................................................................................................. 6 
2.6 Data Collection Methods .............................................................................................................. 7 
2.7 Laboratory Methods ..................................................................................................................... 9 
2.8 Quality Control of Field Work ..................................................................................................... 10 
2.9 Data Management ...................................................................................................................... 10 
2.10 Data Analysis ............................................................................................................................. 11 
3. RESULTS              12 
3.1 Sample Realisation and Survey Profile ....................................................................................... 12 
3.2 Sample Description and Characteristics ..................................................................................... 13 
3.3 Infant HIV Infection Prevalence .................................................................................................. 16 
3.4 National and Provincial Infant HIV Exposure and MTCT Rates................................................... 16 
3.5 National PMTCT Programme Cascade ........................................................................................ 17 
3.6 Demographic Characteristics, MTCT and the PMTCT Cascade by Province ............................... 20 
3.7 Infant Feeding ............................................................................................................................. 38 
4. DISCUSSION              40 
4.1 Infant HIV Exposure .................................................................................................................... 40 
4.2 Mother-to-Child Transmission of HIV ......................................................................................... 40 
4.3 PMTCT Cascade .......................................................................................................................... 42 
4.4 Early Infant Diagnosis ................................................................................................................. 43 
4.5 Infant Feeding ............................................................................................................................. 43 
5. STRENGTHS AND LIMITATIONS OF SAPMTCTE          44 
Strengths ........................................................................................................................................... 44 
 v 
 
Limitations…………………………………………………………………………………………………………………………………..44 
6. CONCLUSION AND RECOMMENDATIONS          45 
REFERENCES…………………………………………………………………………………………………………………………………….47 
CO-INVESTIGATORS…………………………………………………………………………………………………………………………50 
SAMPLE SIZE CALCULATION BY PROVINCE……………………………………………………………………………………….52 
SAMPLING……………………………………………………………………………………………………………………………………….53 
 
 
TABLES 
Table 1  2010 South African national PMTCT regimens .......................................................................... 2 
Table 2  Studies conducted on PMTCT effectiveness, SA, 2001-2009 .................................................... 2 
Table 3  Data collection start and end dates in each province ............................................................... 7 
Table 4  2010 SAPMTCTE desired and actual sample size by province ................................................ 12 
Table 5  Selected socio-demographic observations of 2010 SAPMTCTE [# (%)] .................................. 14 
Table 6  Weighted Infant HIV infection prevalence nationally and by province .................................. 16 
Table 7  Weighted infant HIV exposure and 4-8 week (early) MTCT of HIV by province ..................... 17 
Table 8 HIV testing & results among pregnant women (weighted analysis)……………………………………..18 
Table 9  PMTCT programme in reported HIV-positive mothers (weighted analysis) ........................... 19 
Table 10  Baseline characteristics of Eastern Cape SAPMTCTE survey participants ............................. 21 
Table 11  Baseline characteristics of Free State SAPMTCTE survey participants ................................. 22 
Table 12  Baseline characteristics of Gauteng SAPMTCTE survey participants .................................... 24 
Table 13  Baseline characteristics of KwaZulu-Natal SAPMTCTE survey participants .......................... 26 
Table 14  Baseline characteristics of Limpopo SAPMTCTE survey participants .................................... 28 
Table 15  Baseline characteristics of Mpumalanga SAPMTCTE survey participants ............................ 30 
Table 16  Baseline characteristics of Northern Cape SAPMTCTE survey participants .......................... 32 
Table 17 Baseline characteristics of North West SAPMTCTE survey participants ................................ 34 
Table 18  Baseline characteristics of Western Cape SAPMTCTE survey participants ........................... 36 
Table 19 Infant feeding practices amongst HIV exposed infants over the past 8 days by province .... 39 
 
FIGURES 
Figure 1  Using ELISA at biomedical marker to identify HIV-exposed infants......................................... 4 
Figure 2  Design phase and data collection flow diagram for the cell-phone data collection system ... 8 
Figure 3 Example of SAPMTCTE Mobile Researcher web-based interface ............................................. 8 
Figure 4  2010 SAPMTCTE study profile ................................................................................................ 13 
Figure 5  PMTCT service uptake (PMTCT cascade) in South Africa ....................................................... 20 
Figure 6  PMTCT service uptake (PMTCT cascade) in the Eastern Cape ............................................... 22 
Figure 7  PMTCT service uptake (PMTCT cascade) in the Free State .................................................... 24 
Figure 8  PMTCT Service Uptake (PMTCT cascade) in Gauteng ............................................................ 26 
 vi 
 
Figure 9  PMTCT service uptake (PMTCT cascade) in KwaZulu-Natal ................................................... 28 
Figure 10  PMTCT service uptake (PMTCT cascade) in Limpopo .......................................................... 30 
Figure 11  PMTCT service uptake (PMTCT cascade) in Mpumalanga ................................................... 32 
Figure 12  PMTCT service uptake (PMTCT cascade) in the Northern Cape .......................................... 34 
Figure 13 PMTCT service uptake (PMTCT cascade) in the North West Province ................................. 36 
Figure 14   PMTCT service uptake (PMTCT cascade) in the Western Cape Province ........................... 38 
Figure 15  Maternal antenatal HIV prevalence by province in South Africa......................................... 40 
Figure 16  NHLS Early Infant Diagnosis PCR <2 months old 2008-2010 (from Sherman, 2010) ........... 41 
 vii 
 
PRIMARY CONTACTS/PRINCIPAL INVESTIGATORS 
 
Ameena Goga, MD 
Paediatric Epidemiologist 
Medical Research Council, SA 
 
Address: 1 Soutpansberg 
Road, Pretoria, 0001,  
Phone: +2782 302 3168 
 
e-mail: 
Ameena.Goga@mrc.ac.za 
 
Thu-Ha Dinh, MD, MS 
Medical Epidemiologist 
Centers for Disease Control and 
Prevention 
Address: 1600 Clifton Rd 
Atlanta, 30333 
Phone: +1 404 639 8618 
             +2712 424 9000 
e-mail: dvt1@cdc.gov;  
 dinht@sa.cdc.gov 
Debra Jackson, RN MPH DSc 
Professor (Extraordinary) 
School of Public Health 
Univ. of the Western Cape 
Address: PBX17 Modderdam 
Road, Bellville 7535 
Phone: +2783 327 7331 
 
e-mail:  
debrajackson@mweb.co.za 
 
 
ACKNOWLEDGEMENTS  
 
 CDC and PEPFAR for technical and financial support.  
 UNICEF for financial support. 
 CHAI for funding the situational assessment that preceded this survey. 
 NICD/NHLS for conducting the validation ELISA testing on DBS samples; for providing 
consumables for the survey and for performing all the DBS ELISA and PCR testing. In 
particular thanks go out to Ms Beverly Singh. Ushimta Patel and Ewalde Cutler. 
 Ms Tsakani Mhlongo for training data collectors on infant blood drawing procedures. 
 The National and Provincial Departments of Health. 
 District and facility managers who provided support for the SAPMTCT Evaluation. 
 Mothers and their infants who participated in the survey. 
 MRC survey supervisors and data collectors. 
 WHO for protocol support. 
  
 viii 
 
ABBREVIATIONS AND ACRONYMS 
AIDS  Acquired Immunodeficiency Syndrome 
ANC   Antenatal Care 
ART  Antiretroviral therapy 
ARV  Antiretroviral (drug) 
BCC  Behaviour Change Communication 
CDC  Centers for Disease Control and Prevention 
CHAI   Clinton Health Access Initiative 
DBS   Dried Blood Spot 
DHIS  District Health Information System 
DHS  Demographic and Health Survey 
DNA PCR DNA-based Polymerase Chain Reaction Test  
EBF   Exclusive Breast-Feeding 
EID  Early Infant Diagnosis 
ELISA  Enzyme-linked Immunosorbent Assay 
HAART   Highly Active Antiretroviral Therapy  
HIV  Human Immunodeficiency Virus 
HIER  Health Information, Evaluation & Research 
HSRC  Human Sciences Research Council 
HSRU  Health Systems Research Unit of the Medical Research Council 
IMCI  Integrated Management of Childhood Illnesses 
LPT  Late Post-partum Transmission 
M&E  Monitoring and Evaluation 
MCWH  Maternal Child & Women’s Health  
MCH   Maternal and Child Health  
MDG  Millennium Development Goals 
MPH  Masters in Public Health 
MRC  Medical Research Council 
MTCT  Mother-to-child transmission (of HIV) 
NDOH  National Department of Health 
NHLS  National Health Laboratory Service 
NICD  National Institute for Communicable Diseases 
NRF  National Research Foundation 
NSP  National Strategic Plan, South Africa, 2007-2011 
PEPFAR  President’s Emergency Plan For AIDS Relief 
PITC  Provider-Initiated Testing and Counseling 
PSU  Primary Sampling Unit 
PMTCT  Prevention mother-to-child transmission of HIV 
RtHC  Road to Health Chart  
SAPMTCTE South African Prevention of Mother-to-Child Transmission Evaluation 
Sd-NVP  Single-dose Nevirapine  
 ix 
 
SoPH  School of Public Health, University of the Western Cape 
UNICEF  United Nations Children’s Fund 
UNGASS United Nations General Assembly, Special Session 
UWC  University of the Western Cape 
WHO  World Health Organisation 
  
 x 
 
EXECUTIVE SUMMARY 
Introduction 
Within ten years of implementing the national Prevention of Mother-to-Child Transmission of HIV 
(PMTCT) programme in South Africa interventions to prevent mother-to-child transmission (MTCT) 
of HIV are now offered in more than 95% of public antenatal and maternity facilities country-wide. 
However, this is the first national evaluation to determine the effectiveness of the National PMTCT 
programme.  The 2010 South African PMTCT Evaluation (SAPMTCTE) will serve as a baseline to 
monitor the effectiveness of the antenatal and intrapartum aspects of the national PMTCT 
programme (i.e., early MTCT rates). The survey will be repeated in 2011 and 2012 (during which 
postnatal transmission at 6, 9, 12 and 18 months will also be measured) to track progress with 
reduction in MTCT rates during pregnancy, labour and delivery, and postpartum. This will provide a 
field-based, systematic approach to estimating the overall population-based transmission rate and 
the number of new paediatric infections at 4-8 weeks of infant age. 
Aims and Objectives 
The overall aim of this evaluation was to conduct a national facility-based survey to monitor the 
effectiveness of the South African National PMTCT programme. The primary objective was to 
measure rates of early MTCT of HIV at six weeks postpartum.  The secondary objective was to 
periodically estimate coverage of key PMTCT interventions and services (e.g., HIV testing, CD4 cell 
count testing, infant antiretroviral (ARV) prophylaxis, infant feeding counselling).  
Methods 
A cross-sectional facility-based survey was conducted at immunisation service points at public 
primary health care/community health centres (PHC/CHC) in all nine provinces. This methodology 
was chosen as immunisation uptake at 6 weeks is >99% in South Africa. The survey aimed to capture 
known and unknown HIV-exposed infants, as well as PMTCT participants and non-participants. A 
biomedical marker (HIV enzyme-linked Immunosorbent Assay (ELISA) tests to identify HIV antibody) 
was used to identify HIV-exposed infants from infant dried blood spot (DBS) specimens. All DBS 
specimens reactive on ELISA testing were sent for DNA-based polymerase chain reaction tests (DNA 
PCR) to determine infant HIV infection status. 
 
Infants aged 4-8 weeks attending PHC/CHC facilities for their six week immunisation were included. 
Hospitals and mobile clinics, very sick infants or infants aged <4 weeks or >8 weeks were excluded. 
The immunisation data from the 2007 District Health Information System (DHIS) were used to 
quantify the number of children that could be expected within facilities over a period of time and 
then stratify by size. Sample size was calculated so that valid national and provincial level estimates 
of MTCT could be ascertained. This resulted in between 34-79 facilities per province, 580 in total. 
Facilities were randomly selected within strata with probability proportional to size (3 strata). 
Caregiver/infant pairs were consecutively or randomly selected from facilities (depending on facility 
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size). Interviews were conducted and infant DBS drawn after receiving consent from caregivers for 
study participation. Mothers and infants were referred into HIV care, as appropriate. Data were 
collected using low cost cell phones and interview data were uploaded real time into a web-based 
database console. Analysis was weighted for sample realisation and at provincial level proportional 
to the live birth distribution of South Africa. 
Results 
A total of 10 820 eligible infants were identified from 572 facilities. Of these, 10 735 interviews were 
conducted and 10 178 (94%) DBS were drawn and analysed.  
 The national weighted infant HIV-exposure prevalence was 32.0% (95% CI 30.7-33.3%).  
 The national weighted MTCT rate measured at 4-8 weeks of infant age was 3.5% (95% CI 2.9-
4.1%).  
 The MTCT rate across provinces ranged from 1.4% to 5.9%. 
 Among mothers who reported being HIV negative, 4.1% had HIV-exposed infants.  
 Of all women participating 98.8 (95% CI 98.5-99.0%) received an HIV test during pregnancy 
and of these 98.6 (95% CI 98.4-98.9) got their HIV test results. 
 Of the reported HIV-positive mothers 78.3% had a CD4 cell count done during pregnancy 
and 91.8% received either maternal highly active antiretroviral therapy (HAART) or 
mother/baby antiretroviral (ARV) prophylaxis.   
 Only 35.1% intended to access early infant diagnosis services and 89% had received infant 
feeding counselling. 
 Among HIV-positive women, 20% were exclusively breastfeeding, 62% formula feeding and 
18% mixed feeding in the 8 days prior to the interview. 
Conclusions and Recommendations 
1. The national PMTCT survey found a 3.5% national MTCT rate in pregnancy and intrapartum 
with a greater than 4-fold differential range of rates across the nine provinces (1.4% to 
5.9%).   
2. Maternal HIV acquisition since the last HIV test was potentially high at 4.1% and therefore 
repeat HIV testing at 32 weeks pregnancy and couple testing is critical. Further data should 
collected to assess the contribution of false negative rapid test results to maternal potential 
HIV acquisition. In addition, more work is required to improve the quality of rapid HIV 
testing in the field. 
3. Uptake of PMTCT services is high, with more than 98% of women getting HIV tested during 
pregnancy and 91.7% of HIV-positive mothers receiving ARV treatment or prophylaxis. 
However CD4 (78.3%) testing and early infant diagnosis (EID) (35.1%) uptake are lower and 
represent on-going missed opportunities in the PMTCT programme. 
4. Early infant HIV testing uptake is high if offered to all infants (94%) at six-week immunisation 
visits, indicating that EID strategies that routinely offer infant HIV testing only to known HIV-
exposed infants should be reviewed. 
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5. Given the measured MTCT rate in the early implementation phase of the revised 2010 South 
African PMTCT guidelines, virtual elimination of paediatric HIV infection is possible with 
intensified effort. However, postnatal transmission after 6 weeks also needs to be examined 
to assess achievement of <5% MTCT at 18 months of infant age. 
6. Only 20% of HIV-positive women were exclusively breastfeeding, 62% were formula feeding 
and 18% were practicing high-risk mixed feeding, suggesting a need for increased attention 
to infant feeding. 
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DEFINITIONS  
Caregiver The person who feeds and looks after the child most of the week. This 
includes parents, legal guardians, family members, nannies or friends 
who routinely feed, bath, change nappies, or in particular reference to 
this study, bring the child for routine health services.  
The Consortium Health Systems Research Unit (HSRU) of the Medical Research Council 
(MRC) and School of Public Health of the University of the Western Cape 
(SoPH, UWC).   
Early (4-8 weeks) HIV 
transmission rate among 
HIV-exposed infants 
Number of DNA PCR positive infants and ELISA positive infants divided 
by the number of ELISA positive infants at 4-8 weeks. 
 
Health care personnel Health care providers and health care workers. 
Health care provider 
 
Any person providing health services in terms of any law, including in 
terms of the: 
 Allied Health Professions Act, 1982 (Act No.63 of 1982), 
 Health Professions Act, 1974 (Act No. 56 of 1974), 
 Nursing Act, 2005 (Act No. 33 of 2005), 
 Pharmacy Act, 1974 (Act No. 53 of 1974), and 
 Dental Technicians Act, 1978 (Act No. 19 of 1979).  
Health care worker Any person who is involved in the provision of health services to a user, 
but is not a health care provider. This includes lay counselors and 
community caregivers.  
HIV-exposed infant An infant born to a known HIV-positive mother and/or having a positive 
HIV antibody test result using DBS ELISA. Infant HIV exposure prevalence 
serves as an indirect marker of maternal HIV prevalence. 
HIV-infected infant An HIV-exposed infant having a positive HIV DNA PCR result. 
HIV-uninfected infant An HIV-exposed infant having a negative HIV DNA PCR result. (Note: In 
many cases, there is on-going risk of postnatal transmission through 
breastfeeding, so an early DNA PCR result indicates infection status at 
the time of the test, but not the final infection status).     
HIV-positive mother Defined for this survey as mothers whose infants have a positive DBS 
ELISA.  
HIV status unknown  Refers to people (including children) who have not taken an HIV test or 
who do not know the result of their test. 
Infant A child from birth to 12 months of age. 
Infant HIV infection 
prevalence 
Proportion of confirmed HIV-positive (infected) infants among all infants 
tested during the study period, measured as number of positive DNA PCR 
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infant DBS divided by the total number of ELISA samples tested. In this 
study infant HIV infection prevalence at 6 weeks will be measured in 
infants age 4 to 8 weeks, who are attending routine immunisation clinic.  
It will be measured as a point prevalence with the numerator defined as 
those infants with a positive HIV DNA PCR test and the denominator of all 
infants tested using HIV ELISA on dried blood spots in the study. 
Maternal HIV prevalence Number of positive (infant) DBS ELISA divided by total number of ELISA 
samples tested. 
Maternal HIV 
Incidence/Maternal 
potential HIV acquisition 
during pregnancy 
The number of positive infant DBS ELISA among mothers reporting an 
HIV-negative status during the interview divided by total number of 
mothers reporting an HIV-negative status during the interview. This 
indicator is likely a combination of the following scenarios:  (i) mothers 
who do not wish to admit positive status and report being HIV negative; 
(ii) mothers who were tested during the window period; (iii) poor 
quality control or performance of rapid tests in the field causing false 
negative results at antenatal care (ANC) on HIV-infected 
women. Reported field sensitivities are as low as 87% to 95% depending 
on the rapid test used; and (iv) true acquisition of HIV after the last HIV 
test.  
Mother-to-child 
transmission (MTCT) 
 
Transmission of HIV from an HIV-positive woman to her infant during 
pregnancy, delivery or breastfeeding. The term is used because the 
immediate source of the infection is the mother, and does not imply 
blame on the mother. 
MTCT rate Defined for this survey as a numerator of HIV-positive infants (PCR 
positive) and denominator of HIV-exposed infants (infant ELISA antibody 
positive).  
Routine offer of 
counselling and testing  
HIV testing that is routinely offered to all ANC clients. Health care 
personnel provide group information first, followed by individually 
offering HIV tests. The patient/client has the option to decline testing at 
any stage of this process. The patient/client receives post-refusal 
counselling or post-test counselling as appropriate.  
Transmission in PMTCT 
programme  
Number of positive DNA PCR and positive ELISA divided by the number 
of ELISA positive mothers who recall taking ARV prophylaxis or HAART 
during pregnancy/delivery. 
Transmission in those not 
participating in PMTCT 
Programme (missed 
opportunities) 
Number of positive DNA PCR and positive ELISA divided by number of 
mothers who do not recall taking ARV prophylaxis or HAART during 
pregnancy/delivery. 
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1. INTRODUCTION  
 
Internationally and nationally PMTCT has been recognised as an essential intervention to reduce HIV 
incidence in the population and to virtually eliminate new HIV infections in children. In 2010 the 
WHO Global Elimination of MTCT Initiative (WHO/UNICEF/UNFPA/UNAIDS, 2011) aims, inter alia, to 
reduce new paediatric HIV infections by 90% from the 2009 estimated baseline and reduce the 
overall, population-based HIV transmission rate (through MTCT) to <5% (<2% in the absence of 
breastfeeding or as measured at 6 weeks).  The South African National Strategic Plan on HIV and 
AIDS and STIs, 2007-2012 (NSP) (NDOH, 2007) prioritises scaling up coverage of PMTCT to reduce 
MTCT to less than 5% by 2011.   
 
In 2001 South Africa started implementing a programme to prevent HIV transmission from mother-
to-child at 18-pilot sites. The first interventions included single-dose nevirapine (Sd NVP) during 
labour for the mother and to the baby within 72 hours of delivery; modified obstetric practices; 
infant feeding counselling and the provision of free commercial infant formula to HIV-positive 
mothers who avoided breastfeeding (NDOH, 2001). PMTCT interventions were scaled up in 2002 and 
in 2008 the national antiretroviral regimens for pregnant women were improved to dual therapy 
(AZT from 28 weeks with Sd-NVP at the outset of labour for pregnant women and Sd-NVP with AZT 
for baby).  
 
In 2010, PMTCT interventions were further modified as shown in Table 1 (NDOH/SANAC, 2010). The 
2010 modifications included routine HIV testing and counselling for pregnant women, dual therapy 
to prevent MTCT of HIV, HAART for pregnant women with CD4 cell count ≤350 cells/µl, postnatal 
infant prophylaxis for breastfeeding HIV-positive women and intensified efforts to integrate PMTCT 
services into routine maternal and child health (MCH) services. These efforts are to meet the NSP 
targets of reducing the MTCT rate of HIV to less than 5% by 2011 and to meet the 4th and 6th 
Millennium Development Goals (MDGs) (i.e., ‘reduce by two thirds, between 1990 and 2015, the 
under-five mortality rate’ and ’have halted by 2015 and begun to reverse the spread of HIV/AIDS’) 
(UN, 2011). 
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Table 1  2010 South African national PMTCT regimens 
HIV-infected pregnant women 
Mother Start all HIV-positive pregnant women on AZT at 14 weeks 
Pregnancy CD4 cell count≤350 or WHO clinical stage 
3 or  4: HAART 
Note: WHO stages are defined at the end 
of this section, for your information 
CD4 cell count>350 and WHO stage 
1 or 2 
Start AZT. Same day referral to ARV clinic 
for HAART. Stop AZT once HAART 
initiated 
Continue AZT 300 mg 12 hourly 
Labour and 
delivery 
Continue HAART as usual during labour Single dose nevirapine (200mg) at 
onset of labour + AZT 300mg 12 
hourly until the neonate is delivered 
Postnatally Continue HAART as usual TDF + FTC (Truvada) single dose 
(stat) after delivery 
 
HIV-exposed infants 
Mother breastfeeds  
(and not on HAART) 
Mother meets specified criteria and does not 
breastfeed 
Daily infant nevirapine throughout the 
breastfeeding period until 1 week after 
breastfeeding stops 
Daily infant nevirapine for 6 weeks only 
 
Within ten years of implementing the national PMTCT program in South Africa, PMTCT interventions 
are now offered in more than 95% of antenatal and maternity facilities country-wide. Small scale 
evaluations of MTCT rates have been conducted since 2001 (Table 2) providing results of PMTCT 
effectiveness at selected sites. 
 
The National Health Laboratory Service (NHLS) report on PCR positivity at all sites offering PCR 
testing for infants. In addition, routine DHIS data provide information on the PMTCT programme but 
lack fixed denominators to calculate transmission, and thus PMTCT effectiveness, reliably. 
Consequently, there is not been a national evaluation to determine the effectiveness of the National 
PMTCT programme prior to the 2010 SAPMTCTE.  
 
Table 2  Studies conducted on PMTCT effectiveness, SA, 2001-2009 
 <2007 2008 2009 
Sherman (2009) Rahima Moosa  
Hospital record review. (2001-2002) Sd NVP  
8.0%   
6 weeks 
  
Sherman (2004) Coronation 
Hospital record review (2001-2002)  Sd NVP 
8.7% 
6 weeks 
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 <2007 2008 2009 
Coetzee (2006) Khayelitsha   
AZT from 34 wks  (March-November 2003) 
8.8% 
6-10 wks 
  
Colvin (2007) Good Start study:  
3 sites (P, R, U). Prospective cohort study  
(Oct 2002-Nov 2004) 
P: 8.6% (4.5–
14.5) 
R: 13.7% (8.9–
19.8) 
U: 11.9% 
(8.3–16.3) 
  
Rollins (2007& 2009) KZN MTCT  
7 clinics Aug 04–July ‘05 
3 PHC facilities Nov ‘07- Feb ‘08, 
20.2%  
4-8 weeks 
21.9% 
4-8 weeks 
 
Sherman (2010) National MTCT NHLS data ≤ 
2months  
 8.2% 5.8% 
 
The 2010 SAPMTCTE will serve as baseline, and progress will be monitored over two subsequent 
years during which postnatal transmission will also be measured and field estimates of overall 
population-based transmission and new paediatric HIV infections will be calculated.  
 
The 2010 SAPMTCTE aimed to conduct a facility-based survey to monitor the effectiveness of the 
South African National PMTCT programme. The primary objective of the 2010 SAPMTCTE was to 
measure rates of early MTCT of HIV at 4-8 weeks postpartum.  The secondary objective was to 
periodically estimate coverage of key PMTCT interventions and services (e.g., HIV testing, CD4 cell 
count testing, infant ARV prophylaxis, infant feeding counselling). 
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2. METHODOLOGY  
2.1 Survey Design and Justification 
A cross-sectional facility-based survey, using a biomedical marker to determine MTCT rate, was 
conducted.  The survey was conducted among caregiver-infant pairs who presented at their local 
primary health care facility for their infant’s six-week immunisation (1st DTP dose) visit.  South Africa 
reports >95% coverage of six week immunisation (1ST DTP dose) (WHO, 2011), making these clinics  
an ideal catchment point for young infants -- of  known or unknown HIV exposure status. This 
provided a convenient sample to determine overall PMTCT effectiveness with relatively limited 
selection bias.  
 
This methodology has been proven effective in a South African context. Based on the approach 
recommended by Rollins et al. (2007 & 2009) we used a biomedical marker to identify infants 
exposed to HIV. Chantry et al. (1995) found that sero-reversion for ELISA in HIV-exposed infants was 
not seen prior to 17 weeks of age suggesting that most, if not all, infants aged 4-8 weeks will still 
have maternal antibodies in their bloodstream. This means that screening infants for the presence of 
HIV antibody would be a direct measure of infant HIV exposure and an indirect measure of maternal 
HIV infection prevalence. 
 
Figure 1  Using ELISA at biomedical marker to identify HIV-exposed infants 
 
 
Mom's HIV antibody
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This evaluation thus aimed to provide:  
1) A valid estimate of MTCT and HIV infection prevalence in children aged 4-8 weeks,  and 
2) A reasonable estimate of coverage of key PMTCT programme indicators through 6 weeks 
postpartum.    
2.2 Study Population and Inclusion/Exclusion Criteria 
The study population comprised infants aged 4-8 weeks and their caregivers visiting public health 
facilities for the infant’s 1st DTP dose between June-December 2010.  
 
Inclusion Criteria 
Study participants included 4-8 week old infants attending clinic for 1st DTP immunisation.  
Caregivers had to consent to participation (consent for maternal or caregiver interview and/or infant 
DBS).  
  
Exclusion Criteria 
Severely ill infants needing emergency medical care or urgent referral to the next level of care (e.g., 
infants who are vomiting everything or have convulsions; are lethargic or unconscious; or have 
severe pneumonia or severe dehydration) were excluded from the study.  
2.3 Sampling  
Sampling Frame 
The public health facilities were stratified as: < 130, 130-300 and >300 immunisations per year, and 
data were extracted from the 2007 South African DHIS (Personal Communication C Hedberg, 2009). 
A strategic decision was made to exclude the small facilities (<130 immunisations per year) from the 
formal sampling frame. The 2008 national antenatal maternal HIV prevalence estimate of 29% 
(NDOH, 2009) was used as the cut-off point for classifying facilities as above or below national 
average for antenatal HIV prevalence. This stratification was only applied to facilities in the large 
stratum (>300 immunisations per year). A total of 23 strata across province, facility size and 
maternal HIV prevalence were utilised in the survey sampling frame and were sorted by province, 
size and maternal HIV prevalence. 
 
Sample Size  
ANC maternal HIV prevalence (NDOH, 2009) and estimated MTCT rates from a KwaZulu-Natal survey 
using similar methodology (Personal communication N. Rollins, unpublished data, 2009) were used 
to determine the sample size for each province. Specifying relative precisions of 30% to 50% for the 
expected MTCT rate across provinces plus a design effect of 2 indicated that a total sample size of 12 
200 infant DBS specimens were needed. The sample size across provinces ranged from 1 800 
(Gauteng) to 700 (Northern Cape).  
 
 
 
 6 
 
Sampling 
Stratified two-stage sampling was used. In the first stage, facilities (Primary sampling units - PSUs) 
were randomly sampled proportional to size (PPS) within each stratum. The method operated under 
the without-replacement-type selection (Lehtonen & Pakhinen, 1994). At the second stage a fixed 
number of infants per a facility was sampled. The fixed number was the median number of infants 
expected within the sampling window (three weeks) across the population of facilities within the 
stratum as determined from the detailed information of the sampling frame above. The fixed 
number of infants sampled in each facility within a stratum ensured a self-weighting sample. A 
sampling window of 3 weeks was used to realize the required sample. (Appendix#1) 
2.4 Data Collection Tools  
Data were gathered using a questionnaire adapted from several validated tools (Rollins et.al., 2007 
& 2009; HSRC, undated; Nyblade & MacQuarrie, 2006; Tlebere et.al., 2007; Jackson et al. 2007).  The 
questionnaire included information on maternal age, parity, socio-economic status, antenatal care, 
HIV testing,  maternal HIV status, PMTCT care during pregnancy and delivery, infant feeding 
counselling, birth information, infant feeding practices, infant weight; immunisations, postnatal visits 
and illness since birth. Fathers/legal guardians/non-maternal caregivers were administered a shorter 
form of the questionnaire that excluded ANC and PMTCT information.  
 
The study tool was piloted in the Western Cape and KwaZulu-Natal provinces to test it in English and 
at least one other official/local languages.  Approximately 5-10 participants were administered the 
study tool in each language as part of the pilot. The primary objective was to test the flow of 
questions and basic understanding by the participants. The cell phone technology used for data 
collection, including skips and field data entry, was also examined and tested. Adjustments to the 
tool and/or cell phone data entry platform were made after the pilot as necessary. 
2.5 Ethical Considerations 
Written, signed, informed consent for all procedures in the study was obtained from each eligible 
caregiver for the interview and DBS sampling (separately). Informed consent was in the preferred 
language of the participants. The information sheet was written in plain lay words that could be 
easily understood by participants. A confidential Study ID was given to each participant and inserted 
in consent forms, lab forms and questionnaire for the purpose of data linking and auditing, and to 
provide the infants’ blood test results to mothers or legal guardians. Care was taken to ensure that 
HIV-infected mothers who refused the study understood that their infant could be tested without 
participating in the study. 
 
Ethical approval was obtained from the Medical Research Council (26 February 2010) and from each 
of the nine provincial research ethics committees. Ethical approval was also granted from the United 
States Centers for Disease Control and Prevention Atlanta (April 2010).  
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2.6 Data Collection Methods  
Data collection commenced at different times in each province (Table 3).  All data collection was 
completed by 1 December 2010.  
 
Table 3  Data collection start and end dates in each province 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Enrolment  
Data collectors recruited mothers/caregivers from the PHC/CHC waiting room during immunisation 
days. Data collectors introduced themselves and the study verbally and in written form using a 
standardised information sheet. If the mother agreed to be interviewed, the interview was 
conducted in a private location. Mother/Infant pairs attending the sampled facilities to receive the 
infants’ DPT first dose vaccination were approached to enroll in the study. A screening questionnaire 
was administered to determine eligibility and full informed consent forms were completed. 
 
Cell Phone Technology for Data Collection  
Electronic questionnaires were loaded on low-cost mobile phones using the Mobile Researcher 
software management solution. The Mobile Researcher system consists of three components: the 
handset, the web interface (data transport system) and web-based research console (Figure 2). The 
handset is the device on which the questionnaires are entered. Minimum handset functionality is 
ensured since phone is WAP (Wireless Application Protocol) enabled. The data is transferred via the 
GPRS (General Packet Radio Services) network using the WAP platform on the mobile phone. The 
web-based management console is a secure data capture centre that has controlled access.  
 
Questionnaires were uploaded as they were completed to the central web management console and 
then removed from the phone, while fieldworkers were in an area of mobile reception. In areas 
where there was no mobile network reception, the questionnaire was stored on the phone until 
reaching an area with adequate mobile network coverage when data would be automatically 
DATA COLLECTION 
Province Commenced Completion 
KwaZulu-Natal 01-June-2010 22-Oct-2010 
Eastern Cape 14-June-2010 12-Nov-2010 
Western Cape 14-June-2010 22-Oct-2010 
Free State 23-June-2010 12-Nov-2010 
North West 23-June-2010 21-Oct-2010 
Gauteng 28-June-2010 29-Oct-2010 
Limpopo 29-June-2010 12-Nov-2010 
Northern Cape 29-June-2010 01-Dec-2010 
Mpumalanga 30-June-2010 29 Oct-2010 
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uploaded. The questionnaire responses were available on the web-based console every minute, 
allowing for real-time monitoring of data collection progress and analysis (Figure 3). 
 
Figure 2  Design phase and data collection flow diagram for the cell-phone data collection system 
 
Figure 3 Example of SAPMTCTE Mobile Researcher web-based interface 
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2.7 Laboratory Methods  
The National Institute for Communicable Diseases, a eivision of the South African National Health 
Laboratory Service (NHLS), conducted the testing. Questionnaires and DBS specimens were linked 
using unique study identification numbers and lab order numbers. DBS specimens collected from 
enrolled and consented infants were tested for HIV by means of a laboratory HIV ELISA test 
(Genscreen HIV antibody assay). In cases where this was reactive (i.e., identified an infant born to an 
HIV-positive mother), a qualitative DNA PCR (Amplicor HIV-1 DNA PCR version 2.0 assay, Roche 
Diagnostics, Branchburg, NJ)  was performed to determine whether the infant was currently HIV-
positive. In the case of a known HIV-positive mother, the study DBS specimens and testing replaced 
the expected routine EID testing.  All results were sent to clinic of origin and returned to mother at 
either 10 or 14 week immunisation visit.  
  
All aspects of the project were carried out according to strict standard operating procedures (SOPs), 
and testing was conducted under conditions of good laboratory practice. Specimens received in the 
laboratory were reviewed against the tracking lists/request form for correctness and adequacy of 
specimens. Each specimen received unique bar-coded identifiers for tracking and data extraction. 
Rejected specimens were accompanied by a rejection form with specified reasons and referred to 
field staff for correction. A tracking list of rejected specimens was held by the lab in electronic 
format.  Specimens were tested and results entered into a LIMS (DISA) system; all results had three 
levels of review.  
 
The algorithm for testing was decided based on the outcome of initial dual ELISA testing. All reactive 
specimens and every 10th non-reactive specimen were tested using a second ELISA, Vironostika 
(bioMérieux, France). A total of 690 specimens were included in the analysis. The agreement 
between the two tests was 99.4% and the sensitivity and specificity of the Genscreen assay was 
99.7% and 99.2% respectively. Based on these results it was decided that a single ELISA test, 
Genscreen, be used. All reactive ELISA tests were referred for DNA testing. In the case of a 
laboratory ELISA equivocal result, HIV DNA testing was performed as a routine.  
 
The procedure for DNA testing was by automated Ampliprep/Taqman v2.0 technology (Roche). 
Evaluation of HIV DNA PCR performance on DBS has demonstrated a sensitivity and specificity of 
99.7% and 100% respectively (Stevens, W et al). The data extraction of ALL ELISA reactive results was 
by location code and the referral of spreadsheet to the DNA testing lab. ALL HIV DNA results were 
extracted and individual reports generated by name of infant for return to the facility where the 
infant was tested. The reports forms were standardised and had all the required information based 
on the original request form. All assays used for surveillance were validated and/or verified prior to 
use, accredited and the performance monitored by proficiency testing. In the case of discordant 
results between the mother’s self-reported result and the laboratory result an algorithm using the 
two ELISAs, Western blot and DNA PCR was performed on the DBS to exclude lab error or false 
positive laboratory results.  
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The data was extracted to exclude personal patient identifiers and emailed to the researchers. The 
extracted data was in Excel format.  Databases were validated and confirmed at two levels before 
release. The Excel spreadsheet was then merged with the questionnaire database fortnightly. 
Laboratory data were sent electronically from the laboratory. Tracking logs (study IDs) were used to 
link questionnaire data and blood test results.  The tracking log was managed by the logistics 
manager. 
  
Prior to the six-week survey, a study was conducted to validate the use of screening and 
confirmatory third generation ELISAs on DBS. This work was headed by Professors Gayle Sherman 
and Adrian Puren, and the samples and funding used for this validation study are part of a separate 
protocol. 
 2.8 Quality Control of Field Work  
Every attempt was made to minimise errors which may result in variation in the collected data 
contributing to bias in the results. Quality control (QC) was defined as the operational procedures 
undertaken within the survey, as prescribed by the survey SOPs, to verify that the survey activities 
(e.g., interviews, obtaining informed consent forms, pre-test counselling, DBS collection, recording  
data, reporting data) were conducted in accordance with the defined quality standards. The SOPs 
focused on QC activities done by the field worker, field worker supervisor, quality control officer and 
the central team. QC activities aimed to improve the quality and validity of the collected data by:  
 Identifying factors that may affect the accuracy and reliability of the data and addressing the 
identified factors;  
 Preventing and correcting errors in the collection of data; and    
 Ensuring that field activities align with the study SOPs.  
2.9 Data Management   
Data captured on the phones were protected with a write-only security model. Fieldworkers could 
modify and review data while the interview was in progress. Captured data was encoded and stored 
on the device in the Record Management system which ensured that only the Mobile Researcher 
application could access the data.  
 
The data was transferred securely to the web console, which uses 128-bit strength encryption. Data 
storage and back up protocols are compliant to enterprise standards and database servers run RAID 
to ensure redundancy in case of disk failure.  
 
The uploaded data was reviewed daily to ensure that all fieldworkers were submitting responses in 
accordance to scheduled work plans. The work plans were developed to achieve the required 
number of DBS per facility and key questions were identified in the database to estimate and track 
the collection of blood sample progress.  
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Questionnaire data was maintained by Mobile Researcher and exported to Excel for data analysis.  
Anonymised laboratory data (Study ID only) were exported to Excel for merging with questionnaire 
data. Consent verification from hard copy consent forms were entered into Excel and double 
checked.  Interim data analysis was completed during the course of the study. Data from 
questionnaire, laboratory results and consent verification were all merged and cross-checked.  Data 
without consent verification was not included for analysis.  Duplicates and other inconsistencies 
across data sets were checked and cleaned according to data standards.  Out-of-range and data 
consistency checks were completed as a component of initial data analysis. 
2.10 Data Analysis 
Sample Realisation 
A total 572 of the 585 sampled clinics were included in final sample. Reasons for non-inclusion 
included clinic closure (temporary or permanent) or no longer administering immunisations. The 
overall realisation was 81% with three provinces having low realisation (Northern Cape, Eastern 
Cape and Limpopo).  
 
Sample Weights 
Sample weights were calculated for the survey to adjust for differential sampling design across 
provinces and the sample realisation (as outlined above). The data from provinces were weighted by 
using the proportional distribution of number of life births observed in 2008 for South Africa over 
provinces. The realisation weights were done at the district or provincial level depending on the 
sampled size and realisation within strata. For Northern Cape and Eastern Cape the realisation 
weighting was done at the provincial level. The realisation weights pertain to the per protocol 
sample size. 
 
A survey analysis was done which took into account the stratification, the different sampling stages 
and the finite number of PSUs involved. A weighted analysis was done to obtain national estimates 
as well as provincial estimates. The infant HIV infection prevalence was estimated at the national 
population level and in the HIV exposed sub-population. These estimates all have 95% confidence 
intervals. Design effects are also reported. The survey specification and analysis was done in SAS 
version 9.2. Descriptive statistics of the demographic profile of the participants was done by 
province and country-wide, accounting for the survey design and realisation. 
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3. RESULTS 
3.1 Sample Realisation and Survey Profile 
Table 4 indicates the desired and actual sample size for questionnaire plus DBS sample and realised 
sample size per province and nationally.  All but three provinces realised at least 80% of sample.  
 
Table 4  2010 SAPMTCTE desired and actual sample size by province 
Province Desired SS 
Actual SS # 
(% Desired SS) 
Eastern Cape  1400  776 (55%)  
Free State  1300  1143 (88%)  
Gauteng  1800  1735 (96%)  
KwaZulu-Natal  1400  1224 (87%)  
Limpopo  1400  1022 (73%)  
Mpumalanga  1600  1286 (80%)  
Northern Cape  700  444 (63%)  
North West  1200  1171 (98%)  
Western Cape  1400  1381 (99%)  
South Africa 12 200  10 182 (83%) 
 
Weighting during analysis adjusted estimates in all provinces with lower than expected sample 
realisation. 
 
Figure 4 details the final study profile for the survey.  Of the eligible participants sampled 99.2% 
(10735/10820) consented for the study; 5% of these (557) had questionnaires but no DBS sample 
(refused or difficult heel stick blood draw). Twenty-four (0.2%) DBS were found insufficient for full 
analysis in the lab.  Therefore of 10 820 eligible infants from sampled clinics during the study period 
(2-4 weeks per clinic), the final sample with questionnaire and analysed DBS was 10 154 (94%) 
infants.  
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3.2 Sample Description and Characteristics 
Table 5 provides a summary of selected characteristics of the SAPMTCTE survey sample. 
Interview + DBS 
10178 (94%) 
Interviewed but no infant DBS 
557 (5%) 
Interviewed 
10735 
Eligible infants 
10820 
Refused to participate in study 
85 (0.8%) 
Insufficient DBS 
24 (0.2%) 
Interview + DBS analysed 
10154 (94%) 
Figure 4  2010 SAPMTCTE study profile 
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Table 5  Selected socio-demographic observations of 2010 SAPMTCTE [# (%)] 
Characteristics Categories ZA EC FS GP KZN LP MP NC NW WC 
Relationship to 
child 
Mother 10357 (96.7) 840 (95.3) 1136 (96.9) 1767 (98.4) 1293 (96.5) 1026 (93.8) 1272 (95.0) 449 (97.6) 1171 (97.0) 1403 (97.1) 
Caregiver 378 (3.3) 41 (4.7) 37 (3.1) 30 9 (1.6) 47 (3.5) 68 (6.2) 66 (5.0) 11 (2.4) 36 (3.0) 42 (2.9) 
Infant gender 
Male 5420 (50.6) 459 (52.1) 602 (51.6) 932 (52.1) 647 (47.9) 551 (50.3) 672 (50.3) 225 (48.9) 614 (50.9) 718 (49.7) 
Female 5315 (49.4) 422 (47.9) 865 (48.4) 865 (47.9) 693 (52.1) 543 (49.7) 666 (49.7) 235 (51.1) 593 (49.1) 727 (50.3) 
Age of mother Mean (SE) 25.9 (0.1) 25.1 (0.2) 25.8 (0.2) 26.6 (0.1) 24.9 (0.2) 26.0 (0.2) 25.3 (0.1) 25.8 (0.2) 26.3 (0.2) 26.4 (0.1) 
Education of 
mother 
None 231 (1.9) 22 (2.5) 11 (0.9) 28 (1.5) 21 (1.5) 17 (1.6) 40 (3.0) 16 (3.5) 64 (5.3) 12 (0.8) 
Grade 1-7 1699 (14.9) 192 (21.8) 180 (15.1) 197 (10.9) 193 (14.5) 164 (15.3) 241 (17.9) 84 (18.3) 230 (19.1) 218 (15.1) 
Grade 8-12 8193 (77.1) 624 (70.8) 928 (79.4) 1437 (80.2) 1064 (79.5) 823 (75.0) 1007 (75.2) 342 (74.3) 867 (71.8) 1101 (76.2) 
Above Grade12 538 (5.4) 39 (4.4) 43 (3.7) 130 (7.1) 54 (4.0) 84 (7.5) 28 (2.1) 14 (3.0) 40 (3.3) 106 (7.3) 
Marital status of 
mother 
Single 7799 (74.4) 668 (75.8) 743 (63.5) 1265 (69.9) 1214 (90.7) 759 (69.7) 1000 (74.8) 359 (78.0) 1004 (83.1) 787 (54.3) 
Married/cohabitating 2850 (24.9) 210 (23.8) 424 (36.0) 518 (29.4) 121 (8.9) 331 (30.0) 322 (23.9) 97 (21.1) 193 (16.0) 634 (44.0) 
Widowed/divorced/ 
separated 
51 (0.4) 2 (0.2) 3 (0.3) 10 (0.3) 1 (0.1) 3 (0.2) 4 (0.3) 2 (0.4) 5 (0.4) 21 (1.4) 
Main building 
material of house 
Brick/Cement block 8070 (73.6) 556 (63.1) 922 (78.6) 1384 (77.1) 830 (61.9) 974 (89.2) 1152 (85.7) 370 (80.4) 891 (73.8) 991 (68.5) 
Informal material 1944 (17.8) 104 (11.8) 234 (19.8) 234 (22.7) 170 (13.3) 92 (8.3) 109 (8.4) 86 (18.7) 290 (24.0) 449 (31.1) 
Traditional material/mud 721 (8.6) 221 (25.1) 17 (1.5) 3 (0.2) 340 (24.8) 28 (2.5) 77 (5.9) 4 (0.9) 26 (2.2) 5 (0.4) 
Main source of 
drinking water 
  
Piped in house or yard 8172 (72.3) 373 (42.3) 990 (85.1) 1657 (92.5) 819 (60.6) 511 (47.4) 1119 (83.9) 430 (93.5) 916 (75.9) 1357 (93.9) 
Not piped in house or yard 2563 (23.2) 508 (57.7) 183 (14.9) 140 (7.5) 521 (39.4) 583 (52.6) 219 (16.1) 30 (6.5) 291 (24.1) 88 (6.1) 
Type of toilet 
  
  
  
Flush toilet  5676 (50.9) 233 (26.4) 777 (66.4) 1525 (84.8) 319 (24.4) 183 (17.4) 393 (30.3) 403 (87.6) 532 (44.1) 1311 (90.7) 
Pit latrine 4659 (41.3) 554 (62.9) 366 (31.1) 260 (14.5) 971 (71.9) 838 (76.1) 901 (66.5) 36 (7.8) 652 (54.0) 81 (5.6) 
None 300 (2.3) 85 (9.6) 2 (0.2) 10 (0.6) 50 (3.8) 68 (6.0) 40 (2.9) 10 (2.2) 16 (1.3) 19 (1.3) 
Other 100 (0.5) 9 (1.0) 28 (2.3) 2 (0.1) 0 (0.0) 5 (0.4) 4 (0.3) 11 (2.4) 7 (0.6) 34 (2.4) 
Main source of 
fuel 
Electricity/gas/ 
paraffin 
9874 (91.9) 862 (97.8) 1143 (97.3) 1782 (99.2) 1121 (83.4) 770 (71.4) 1184 (88.3) 449 (97.6) 1128 (93.5) 1435 (99.3) 
Other 861 (8.1) 19 (2.2) 30 (2.7) 15 (0.8) 219 (16.6) 324 (28.6) 154 (11.7) 11 (2.4) 79 (6.5) 10 (0.7) 
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Characteristics Categories ZA EC FS GP KZN LP MP NC NW WC 
Depletion of food 
supply in past 12 
months 
Yes 1776 (16.4) 216(24.5) 159 (13.7) 170 (9.8) 284 (21.6) 175 (15.1) 117 (8.9) 50 (10.9) 230 (19.1) 375 (26.1) 
No 8892 (83.1) 661 (75.0) 1012 (86.1) 1622 (89.9) 1047 (77.7) 917 (84.8) 1194 (89.1) 410 (89.1) 973 (80.6) 1056 (73.0) 
Planned 
Pregnancy 
Yes 4147 (38.3) 279 (31.2) 454 (38.5) 856 (47.8) 271 (20.1) 540 (49.9) 567 (42.1) 175 (38.0) 496 (41.1) 509 (35.1) 
No 6219 (58.5) 570 (64.7) 682 (58.4) 911 (50.6) 1027 (76.1) 489 (44.2) 702 (52.7) 273 (59.3) 671 (55.6) 894 (61.9) 
DKN 369 (3.1) 32 (3.6) 37 (3.1) 30 (1.6) 42 (3.2) 65 (5.9) 69 (5.2) 12 (2.6) 40 (3.3) 42 (2.9) 
 
ZA: South Africa EC: Eastern Cape FS: Free State  GP: Gauteng  KZN: KwaZulu-Natal  LP: Limpopo  MP: Mpumalanga  NC: Northern Cape  NW: North West  WC: Western 
Cape  
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Of note is that nationally 96.7% of infants were brought to the clinic by their mothers; 84% mothers 
were >20 years of age; 82.5% mothers had completed grades 8-12 or more of school; 74.4% of 
mothers were single and 16.4% reported running out of food at some time during the past 12 
months. 
3.3 Infant HIV Infection Prevalence 
 
                      Table 6  Weighted Infant HIV infection prevalence nationally and by province 
Province % Infant HIV 
Infection Prevalence 
95% CI 
Eastern Cape  2.0 1.1-2.9 
Free State  2.4 1.6-3.2 
Gauteng  1.1 0.6-1.5 
KwaZulu-Natal  1.9 1.2-2.7 
Limpopo  0.9 0.4-1.5 
Mpumalanga  3.0 2.1-3.8 
Northern Cape  0.3 0.1-0.6 
Northwest  1.9 1.2-2.5 
Western Cape  0.9 0.4-1.5 
National 1.5 1.3-1.7 
 
The national weighted infant HIV infection prevalence among infants aged 4-8 weeks attending child 
health clinics for their six week immunisation was 1.5% (95%CI: 1.3-1.7%). (Table 6) Infant HIV 
infection prevalence is the rate of HIV-positivity among all infants tested regardless of exposure 
which provides an indication of total burden of HIV disease in infants at 4-8 weeks of age. 
 
3.4 National and Provincial Infant HIV Exposure and MTCT Rates 
The national rate of infant HIV exposure was 32.0% (95%CI: 30.7-33.3%), with wide provincial 
variation. (Table 7)  (Note: Infant HIV exposure prevalence is presumed to be roughly equivalent to 
maternal HIV prevalence.) 
 
Among these HIV-exposed infants, the national rate of MTCT of HIV by 8 weeks is 3.5% (95%CI: 2.9-
4.1%), with an almost 3-fold difference between provinces; the lowest rate of 1.4% (95%CI: 0.1-3.4) 
was found in the Northern Cape and the highest rate of 5.9% (95%CI: 3.8-8.0) in the Free State.    
 
It is important to note that for the Eastern Cape and Northern Cape (*) provinces the point estimates 
are correct but the sample precision was less (wider confidence intervals). This was due to the lower 
sample realisation rates, 
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Table 7  Weighted infant HIV exposure and 4-8 week (early) MTCT of HIV by province 
 
3.5 National PMTCT Programme Cascade  
Table 8 presents results for PMTCT programme indicators as per maternal report in all mothers 
interviewed.  The percent of pregnant women with unknown HIV status prior to their first antenatal 
booking who had an HIV test during pregnancy was 98.8.  Maternal receipt of HIV test results was 
also high at 98.6%.  Of ALL mothers enrolled in the survey 29.4% reported being HIV-positive while 
HIV antibody was found in 32% of ALL infants – a 2.6% difference. Of concern is that of those 
mothers who reported being HIV-negative, 4.1% of their infants had HIV antibodies, suggesting a 
high rate of maternal potential acquisition of HIV infection during pregnancy.  This rate also varied 
substantially across provinces from a low of 1.1% in the Western Cape to a high of 7.8% in 
Mpumalanga and Eastern Cape. The indicator ‘Maternal potential HIV acquisition’ is a combination 
of the following scenarios:   
(i) Mothers did not want to admit being HIV-positive and instead, reported being HIV 
negative. However, the 2010 data show that refusals for infant HIV testing were low and 
disclosure was high; thus the contribution that this scenario makes to the indicator is 
probably minimal.   
(ii)  Mothers were tested during the window period.  
(iii)  Poor QC/performance of rapid tests in the field causes false negative results at ANC on 
HIV-infected women. Reported field sensitivities are as low as 87% to 95% depending on 
the rapid test used.  
Province 
Infant HIV exposure 
(%) 
MTCT (%) 95% CI 
Eastern Cape* 30.5 (26.9-34.2) 4.7 (2.4-7.0) 
Free State  31.3 (29.1-33.5) 5.9 (3.8-8.0) 
Gauteng  30.4 (27.9-33.0) 2.5 (1.5-3.6) 
KwaZulu-Natal  44.3 (40.2-48.4) 2.9 (1.7-4.0) 
Limpopo  23.9 (21.8-25.9) 3.6 (1.4-5.8) 
Mpumalanga  37.0 (34.3-39.7) 5.7 (4.1-7.3) 
Northern Cape*  16.0 (13.7-18.3) 1.4 (0.1-3.4) 
Northwest  31.3 (29.0-33.5) 4.4 (2.9-5.9) 
Western Cape  21.0 (17.0-25.0) 3.9 (1.9-5.8) 
South Africa 32.0 (30.7-33.3) 3.5 (2.9-4.1) 
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(iv)  True acquisition of HIV after the last HIV test – which for most mothers was during 
pregnancy. 
 
Table 8  HIV testing & results among pregnant women (weighted analysis) 
Province % ANC HIV Test 
% Tested who 
received result 
% Mothers report 
being HIV-
positive 
%Infants of 
reported HIV-
negative mothers 
who had HIV 
antibody 
Eastern Cape  
97.5  
(96.5-98.6) 
98.1 
(97.1-99.1) 
27.1 
(23.5-30.7) 
7.8 
(5.8-9.7) 
Free State  
98.8  
(98.3-99.2) 
98.9 
(98.5-99.4) 
27.9 
(25.7-30.1) 
5.4 
(4.3-6.4) 
Gauteng  
99.1 
(98.7-99.2) 
99.3 
(98.9-99.6) 
28.3 
(25.8-30.8) 
3.0 
(2.2-3.9) 
KwaZulu-Natal  
98.9 
(98.3-99.2) 
99.5 
(99.1-99.9) 
42.2 
(38.1-46.2) 
3.2 
(2.1-4.4) 
Limpopo  
98.6  
(97.8-99.5) 
97.0 
(95.9-98.1) 
19.4 
(17.3-21.6) 
5.1 
(3.6-6.7) 
Mpumalanga  
98.6 
(97.8-99.3) 
97.1 
(96.3-98.0) 
32.6 
(29.7-35.5) 
7.8 
(5.8-9.7) 
Northern Cape  
99.3 
(98.9-99.8) 
96.7 
(95.7-97.6) 
14.4 
12.2-16.7) 
2.2 
(1.2-3.3) 
North West  
99.2 
(98.8-99.6) 
98.5 
(97.8-99.1) 
28.7 
(26.7-30.6) 
5.4 
(3.9-6.8) 
Western Cape  
98.6 
(97.9-99.3) 
98.8 
(98.3-99.3) 
19.9 
(16.1-23.8) 
1.1 
(0.3-1.9) 
South Africa 
98.8 
(98.5-99.0) 
98.6 
(98.4-98.9) 
29.4 
(28.1-30.7) 
4.1 
(3.7-4.6) 
 
Table 9 further shows PMTCT programme indicators for women who reported being HIV-positive:  
78.3% of HIV-positive mothers reported getting a CD4 test result; taking HAART was reported by 
33.1% of mothers reporting being HIV-positive, while 58.7% of HIV-positive mothers reported 
receiving both maternal and neonatal antiretroviral (ARV) prophylaxis.  These two combined 
suggested that 91.8% of HIV-positive mothers received either HAART or ARV prophylaxis (Figure 5).   
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Table 9  PMTCT programme in reported HIV-positive mothers (weighted analysis) 
Province % Received CD4 Test 
% Received 
ARV/HAART 
% Mother & 
Infant Received 
ARV 
Prophylaxis 
% Intended 
to obtain 
EID @ 6 
weeks 
Eastern Cape  
67.6 
(60.2-75.1) 
23.0 
(16.9-29.0) 
63.5 
(55.3-71.7) 
21.6 
(14.9-28.4)  
Free State  
85.8 
(82.7-89.0) 
37.7 
(33.2-42.2) 
56.4 
(51.6-61.1) 
43.7 
(33.3-54.1) 
Gauteng  
74.6 
(69.8-79.4) 
40.1 
(34.9-45.3) 
52.8 
(47.1-58.4) 
42.5 
(32.6-52.4) 
KwaZulu-
Natal  
85.5 
(82.1-88.8) 
29.4 
(25.5-33.3) 
65.2 
(61.1-69.3) 
41.1 
(30.5-51.6) 
Limpopo  
68.3 
(61.0-75.5) 
33.3 
(27.3-39.4) 
54.3 
(47.3-61.3) 
28.4 
(20.4-36.5) 
Mpumalanga  
69.5 
(65.5-73.5) 
27.5 
(23.3-31.7) 
56.1 
(51.8-60.3) 
29.8 
(23.1-36.5) 
Northern 
Cape  
88.7 
(83.0-94.3) 
28.6 
(19.6-37.6) 
58.7 
(51.1-66.3) 
1.6 
(0.1-4.0) 
North West  
81.7 
(78.3-85.1) 
33.7 
(29.1-38.4) 
57.4 
(52.4-62.5) 
3.6 
(1.6-5.7) 
Western 
Cape  
89.6 
(86.8-92.5) 
34.2 
(27.9-40.6) 
60.0 
(52.7-67.3) 
37.9 
(28.8-47.0) 
South Africa 
78.3 
(76.4-80.4) 
33.1 
(30.8-35.3) 
58.7 
(56.3-61.1) 
35.1 
(30.6-39.6) 
 
Only 35.1% of reported HIV-positive mothers indicated that they planned to obtain early infant 
diagnosis (EID) for their infant during their six week immunisation visit (ranging from 1.6% in 
Northern Cape to 42.5% in Gauteng).  
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Figure 5  PMTCT service uptake (PMTCT cascade) in South Africa  
 
 
Note: The first three indicators apply to all mothers, while the last three apply only to those who 
reported being HIV-positive. Red indicates the percentage receiving HAART while blue indicates the 
percentage receiving ARV prophylaxis.  
 
3.6 Demographic Characteristics, MTCT and the PMTCT Cascade by 
Province 
3.6.1 Eastern Cape 
Eastern Cape achieved a sample realisation of 55%.  This was due to a high number of medium size 
clinics requiring extended resources.  Furthermore in the Eastern Cape many infants presenting for 
six week immunisation were older than 8 weeks of age. This was especially the case in large urban 
clinics. These infants were not eligible for enrolment into the survey. 
 General Description of Provincial Sample 
Table 10 presents characteristics of respondents in the Eastern Cape province. Similar to the national 
trend, the majority of the respondents are single (75.8%) mothers (97.3%), with education level of 
grade 8-12 (70.8%). In comparison with other provinces, Eastern Cape has a significant percentage 
(24.5) of respondents that reported experiencing depletion of food in the household in the last 12 
months. Economic status indicators also show that pit latrines (62.9%) and not piped water (57.7%) 
are utilised by the majority of the respondents.  
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Table 10  Baseline characteristics of Eastern Cape SAPMTCTE survey participants 
Characteristics Categories % 95% CI 
Relationship to child 
Mother 97.3 93.9-96.8 
Caregiver 4.7 3.2-6.1 
Mean  age of mother (range) 25.1 (14-52) 
Infant gender 
Male 52.1 48.7-55.5 
Female 47.9 44.5-51.3 
Education of mother 
None 2.5 1.6-3.4 
Grade 1-7 21.8 18.4-25.1 
Grade 8-12 70.8 67.4-74.3 
Above Grade 12 4.4 3.0-5.9 
Marital status of mother 
Single 75.8 73.1-78.6 
Married/cohabitating 23.8 21.1-26.6 
Main building material of house 
Brick/Cement block 63.1 55.5-70.7 
Informal material 11.8 8.1-15.5 
Traditional material/mud 25.1 18.6-31.5 
Main source of drinking water Piped in house or yard 42.3 34.8-49.8 
  Not piped in house or yard 57.7 50.2-65.2 
Type of toilet 
  
  
  
Flush toilet 26.4 19.6-33.3 
Pit latrine 62.9 56.6-69.1 
None 9.6 5.9-13.4 
Other 1.0 0.4-1.7 
Main source of fuel 
Electricity/gas/paraffin 97.8 96.9-98.8 
Other 2.2 1.2-3.1 
Depletion of food supply in past 12 
months 
Yes 24.5 18.9-30.1 
No 75.0 69.4-80.6 
 
Infant HIV Exposure and MTCT Rate in Eastern Cape Province 
Text box 1 shows that infants’ HIV exposure was 30.5%, with a 2.0% early infant HIV infection 
prevalence and a 4.7% (95%CI: 2.4-7.0) MTCT rate at 4-8 weeks. The larger confidence interval 
attached to this estimate is due to the smaller sample size attained in Eastern Cape. The percent of 
reported HIV-negative mothers whose infants had HIV antibodies (presumed maternal HIV 
acquisition after the initial HIV test) was 7.8% (95% CI 5.8-9.7), the highest in South Africa (along 
with Mpumalanga). 
 
Text Box 1: Eastern Cape infant HIV exposure and MTCT 
Infant HIV Exposure % 
(95%CI) 
Infant HIV infection 
prevalence at  
4-8 weeks 
MTCT @ 4-8 
weeks:%(95%CI) 
%Infants of reported HIV-
negative mothers who had 
HIV antibody 
30.5 (26.9-34.2) 2.0 (1.1-2.9) 4.7 (2.4-7.0) 7.8 (5.8-9.7) 
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PMTCT Service Uptake (PMTCT Cascade) in the Eastern Cape Province 
Figure 6 indicates that Eastern Cape has a fairly high antenatal HIV testing rate (97.5%) but ARV 
prophylaxis/HAART coverage of 86.5%. Coverage of CD4 count and intended EID is low in Eastern 
Cape.  
 
Figure 6  PMTCT service uptake (PMTCT cascade) in the Eastern Cape 
 
 
Note: The first three indicators apply to all mothers, while the last three apply only to those who 
reported being HIV-positive. Red indicates the percentage receiving HAART while blue indicates the 
percentage receiving ARV prophylaxis.  
 
3.6.2 Free State  
The survey attained 88% of targeted sample size in the Free State.  
General Description of Provincial Sample 
In the Free State 63.5% of mothers were single.  More than 85% had piped water and electricity, gas 
or paraffin fuel source, while only 66.4% had a flush toilet. (Table 11) 
 
Table 11  Baseline characteristics of Free State SAPMTCTE survey participants 
Characteristics Categories % 95% CI 
Relationship to child Mother 96.9 96.2-97.7 
Caregiver 3.1 3.2-6.1 
Mean age of mother – mean (range) 25.8 (14-48) 
Infant gender Male 51.6 49.6-53.6 
Female 48.4 46.4-50.4 
Education of mother None 0.9 0.5-1.4 
Grade 1-7 15.1 13.3-16.8 
97.5 98.1 
27.1 
67.6 63.5 
21.6 
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Characteristics Categories % 95% CI 
Grade 8-12 79.4 77.5-81.3 
Above Grade 12 3.7 2.7-4.6 
Marital status of mother Single 63.5 61.0-66.0 
Married/cohabitating 36.0 33.5-38.5 
Main building material of house Brick/Cement block 78.6 76.3-80.9 
Informal material 19.8 17.7-22.0 
Traditional material/mud 1.5 0.9-2.1 
Main source of drinking water 
  
Piped in house or yard 85.1 81.5-88.8 
Not piped in house or yard 14.9 11.2-18.5 
Type of toilet 
  
  
  
Flush toilet  66.4 60.9-72.0 
Pit latrine 31.1 25.5-36.6 
None 0.2 0.0-0.3 
Other 2.3 1.3-3.4 
Main source of fuel Electricity/Gas/Paraffin 97.3 96.1-98.6 
Other 2.7 1.4-3.9 
Depletion of food supply in past 12 
months 
Yes 13.7 11.6-15.8 
No 86.1 84.0-88.2 
 
Infant HIV Exposure and MTCT Rate in Free State Province 
Text Box 2 shows that infants HIV exposure was 31.3% with a 2.4% early infant HIV infection 
prevalence and a 5.9% (95%CI: 3.8-8.0%) MTCT rate at 4-8 weeks is the highest in South Africa. The 
percentage of infants with reported HIV-negative mothers who were actually HIV-exposed 
(presumed maternal HIV acquisition) is also second highest in the country at 5.4% (95%CI: 4.3-6.4). 
 
Text Box 2: Free State Infant HIV Exposure and MTCT 
Infant HIV Exposure % 
(95%CI) 
Infant HIV infection 
prevalence at 4-8 
weeks 
MTCT @ 4-8 
weeks:%(95%CI) 
%Infants of reported 
HIV-negative mothers 
who had HIV antibody 
31.3 (29.1-33.5) 2.4 (1.6-3.2) 5.9 (3.8-8.0) 5.4 (4.3-6.4) 
PMTCT Service Uptake (PMTCT cascade) in the Free State Province 
Figure 7 shows uptake of HIV testing (98.8%) and coverage of ARV prophylaxis/HAART is fairly high in 
Free State (94.1%).  CD4 testing was at 85.8%. The high presumed maternal potential HIV acquisition 
may explain the high MTCT rate although, more detailed investigations are needed to examine 
‘effective coverage’ of the PMTCT cascade (i.e., despite high CD4 cell and HAART/prophylaxis uptake 
adherence to ARVs was low) and support for mothers post-HIV diagnosis and during pregnancy. 
Adherence and care and support data were not gathered in 2010.  
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Figure 7  PMTCT service uptake (PMTCT cascade) in the Free State 
 
 
Note: The first three indicators apply to all mothers, while the last three apply only to those who 
reported being HIV-positive. Red indicates the percentage receiving HAART while blue indicates the 
percentage receiving ARV prophylaxis.  
 
3.6.3 Gauteng 
The SAPMTCTE in Gauteng province attained 96% of targeted sample size. 
General Description of Provincial Sample 
Socioeconomic indicators show that compared to other provinces, participants in Gauteng Province 
have higher rates of flush toilet and electricity, gas or paraffin fuel source (Table 12).  
 
Table 12  Baseline characteristics of Gauteng SAPMTCTE survey participants 
Characteristics Categories % 95% CI 
Relationship to child Mother 98.4 97.8-99.0 
Caregiver 1.6 1.0-2.2 
Mean age of mother  (range) 26.6 (13-49) 
Infant gender Male 52.1 49.8-54.3 
Female 47.9 45.7-50.2 
Education of mother None 1.5 0.9-2.2 
Grade 1-7 10.9 9.3-12.5 
Grade 8-12 80.2 77.7-82.7 
Above Grade 12 7.1 5.4-8.9 
Marital status of mother Single 69.9 65.3-74.4 
Married/cohabitating 29.4 24.8-33.9 
Main building material of house Brick/cement block 77.1 73.3-80.8 
98.8 98.8 
27.9 
85.8 
56.4 
43.7 
37.7 
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Characteristics Categories % 95% CI 
Informal material 22.7 19.0-26.5 
Traditional material/mud 0.2 0.0-0.4 
Main source of drinking water 
  
Piped in house or yard 92.5 90.0-94.9 
Not piped in house or yard 7.5 5.1-9.9 
Type of toilet 
  
  
  
Flush toilet  84.8 81.6-88.0 
Pit latrine 14.5 11.5-17.6 
None 0.6 0.0-1.2 
Other 0.1 0.0-0.3 
Main source of fuel Electricity/gas/paraffin 99.2 98.8-99.6 
Other 0.8 0.4-1.2 
Depletion of food supply in past 12 
months 
Yes 9.8 7.3-12.3 
No 89.9 87.4-92.4 
 
Infant HIV Exposure and MTCT Rate in Gauteng  
Text Box 3 shows that infants’ HIV exposure was 30.4%, with a 1.1% early infant HIV infection 
prevalence and a 2.5% (95%CI: 1.5-3.6%) MTCT rate at 4-8 weeks. Maternal potential HIV acquisition 
was 3% (2.2-3.9%).  
 
Text Box 3: Gauteng Infant HIV Exposure and MTCT 
Infant HIV Exposure % 
(95%CI) 
Infant HIV infection 
prevalence at 4-8 
weeks 
MTCT @ 4-8 
weeks:%(95%CI) 
%Infants of reported 
HIV-negative mothers 
who had HIV antibody 
30.4 (27.9-33.0) 1.1 (0.6-1.5) 2.5 (1.5-3.6) 3.0 (2.2-3.9) 
 
PMTCT service uptake (PMTCT cascade) in Gauteng 
Gauteng has achieved close to 100% (99.1% tested and 99.3% received test) HIV testing rate. 
Coverage of ARV prophylaxis or HAART is 92.9% with 40.1% of women on HAART, the highest of any 
province. However, CD4 count is only 74.6% and intended EID coverage while higher than other 
provinces is still below half (42.5%).  (Figure 8) 
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Figure 8  PMTCT Service Uptake (PMTCT cascade) in Gauteng  
 
 
Note: The first three indicators apply to all mothers, while the last three apply only to those who 
reported being HIV-positive. Red indicates the percentage receiving HAART while blue indicates the 
percentage receiving ARV prophylaxis.  
 
3.6.4 KwaZulu-Natal 
The SAPMTCTE in KwaZulu-Natal attained 87% of targeted sample size. 
General Description of Provincial Sample 
KwaZulu-Natal had a very high rate of single mothers at 90.7%, while brick/cement block house and 
piped water were just above 60%, and 21.6% of participants described depletion of food supply in 
the past 12 months. (Table 13) 
 
Table 13  Baseline characteristics of KwaZulu-Natal SAPMTCTE survey participants 
Characteristics Categories % 95% CI 
Relationship to child Mother 95.5 95.4-97.5 
Caregiver 3.5 2.5-4.6 
Mean age of mother (range) 24.9 (14-47) 
Infant gender Male 47.9 45.2-50.7 
Female 52.1 49.3-54.8 
Education of mother None 1.5 0.7-2.3 
Grade 1-7 14.5 11.6-17.3 
Grade 8-12 79.5 76.3-82.6 
Above Grade 12 4.0 2.8-5.2 
Marital status of mother Single 90.7 89.0-92.4 
Married/cohabitating 8.9 7.2-10.6 
99.1 99.3 
28.3 
74.6 
52.8 
42.5 
40.1 
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Characteristics Categories % 95% CI 
Main building material of house Brick/Cement block 61.9 55.5-68.3 
Informal material 13.3 9.0-17.6 
Traditional material/mud 24.8 18.3-31.4 
Main source of drinking water 
  
Piped in house or yard 60.6 52.8-68.4 
Not piped in house or yard 39.4 31.6-47.2 
Type of toilet 
  
  
  
Flush toilet  24.4 17.8-30.9 
Pit latrine 71.9 65.2-78.5 
None 3.8 1.0-6.5 
Other 0.0 -- 
Main source of fuel Electricity/Gas/Paraffin 83.4 78.8-88.0 
Other 16.6 12.0-21.2 
Depletion of food supply in past 12 
months 
Yes 21.6 16.2-27.0 
No 77.7 72.3-83.1 
 
Infant HIV Exposure and MTCT Rate in KwaZulu-Natal 
Text Box 4 shows that infants HIV exposure was 44.3%, with a 1.9% early infant HIV infection 
prevalence and a 2.9% (95%CI: 1.7-4.0%) MTCT rate at 4-8 weeks. Among infants whose mothers 
reported being HIV negative 3.2% (95%CI: 2.1-4.4%) were HIV exposed (maternal potential HIV 
acquisition after the initial test).  
 
Text Box 4: KwaZulu-Natal HIV Infant Exposure and MTCT 
Infant HIV Exposure 
% (95%CI) 
Infant HIV 
infection 
prevalence at 4-
8 weeks 
MTCT @ 4-8 
weeks:%(95%CI) 
%Infants of 
reported HIV-
negative mothers 
who had HIV 
antibody 
44.3 (40.2-48.4) 1.9 (1.2-2.7) 2.9 (1.7-4.0) 3.2 (2.1-4.4) 
 
PMTCT service uptake (PMTCT cascade) in the KwaZulu-Natal  
In KwaZulu-Natal, close to 100% of pregnant mothers receive testing and test results. More than 
85% of HIV-positive mothers received their CD4 cell count test result. ARV/ART coverage was also 
high (94.6%).  The high uptake of CD4 cell count results, together with the high percentage of 
pregnant women and infants receiving ARV prophylaxis or HAART may explain the lower MTCT rate 
in KwaZulu-Natal. (Figure 9) Similar to other provinces, coverage of intended EID is low at 41.1%, but 
compared to other provinces, KwaZulu-Natal is the second highest in its EID coverage. 
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Figure 9  PMTCT service uptake (PMTCT cascade) in KwaZulu-Natal 
 
Note: The first three indicators apply to all mothers, while the last three apply only to those who 
reported being HIV-positive. Red indicates the percentage receiving HAART while blue indicates the 
percentage receiving ARV prophylaxis.  
 
3.6.5 Limpopo  
The SAPMTCT Evaluation in Limpopo province attained 73% of targeted sample size. 
General Description of Provincial Sample 
Limpopo showed a slightly higher rate of caregivers (other than mothers) bringing infants to services 
(6.2%) and slightly lower percentage of single mothers (69.7%) compared to South African national 
rates. (Table 14) 
 
Table 14  Baseline characteristics of Limpopo SAPMTCTE survey participants 
Characteristics Categories % 95% CI 
Relationship to child Mother 93.8 92.4-95.2 
Caregiver 6.2 4.8-7.6 
Mean age of mother (range) 26.0 (14-47) 
Infant gender Male 50.3 47.4-53.2 
Female 49.7 46.8-52.6 
Education of mother None 1.6 1.0-2.3 
Grade 1-7 15.3 12.6-18.0 
Grade8-12 75.0 71.9-78.1 
Above Grade12 7.5 6.0-9.0 
Marital status of mother Single 69.7 66.0-73.4 
Married/cohabitating 30.0 26.4-33.7 
Main building material of house Brick/Cement block 89.2 87.2-91.2 
98.9 99.5 
42.2 
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Characteristics Categories % 95% CI 
Informal material 8.3 6.3-10.2 
Traditional material/mud 2.5 1.6-3.5 
Main source of drinking water 
  
Piped in house or yard 47.4 41.5-53.4 
Not piped in house or yard 52.6 46.6-58.5 
Type of toilet 
  
  
  
Flush toilet  17.4 12.4-22.4 
Pit latrine 76.1 71.4-80.8 
None 6.0 4.2-7.9 
Other 0.4 0.1-0.8 
Main source of fuel Electricity/Gas/Paraffin 71.4 65.6-77.2 
Other 28.6 22.8-34.4 
Depletion of food supply in past 12 
months 
Yes 15.1 12.0-18.1 
No 84.8 81.7-87.8 
 
Infant HIV Exposure and MTCT Rate in Limpopo 
Text Box 5 shows that infants’ HIV exposure was 23.9%, with a 0.9% early infant HIV infection 
prevalence and a 3.6% (95%CI: 1.4-5.8%) MTCT rate at 4-8 weeks. Among infants whose mothers 
reported being HIV-negative 5.1% (95%CI: 3.6-6.7%) were HIV-exposed.  
 
Text Box 5: Limpopo HIV Infant Exposure and MTCT 
Infant HIV Exposure % 
(95%CI) 
Infant HIV infection 
prevalence at 4-8 
weeks 
MTCT @ 4-8 
weeks:%(95%CI) 
%Infants of reported 
HIV-negative mothers 
who had HIV antibody 
23.9 (21.8-25.9) 0.9 (0.4-1.5) 3.6 (1.4-5.8) 5.1 (3.6-6.7) 
 
MTCT service uptake (PMTCT cascade) in the Limpopo 
The PMTCT cascade shows that less than 70% of mothers received their CD4 cell count test result 
and 87.6% of HIV positive mothers received ARV prophylaxis or HAART.  (Figure 10) 
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Figure 10  PMTCT service uptake (PMTCT cascade) in Limpopo 
 
Note: The first three indicators apply to all mothers, while the last three apply only to those who 
reported being HIV-positive. Red indicates the percentage receiving HAART while blue indicates the 
percentage receiving ARV prophylaxis.  
 
3.6.6 Mpumalanga 
The SAPMTCTE attained 80% of targeted sample size in the province of Mpumalanga. 
General Description of Provincial Sample 
In Mpumalanga more than 80% of study participants have brick/cement block houses, piped water 
in house or yard, and electricity, paraffin or gas cooking fuel, but only 30.3% have a flush toilet.  Only 
8.9% described depletion of food supply in the past 12 months. (Table 15) 
 
Table 15  Baseline characteristics of Mpumalanga SAPMTCTE survey participants 
Characteristics Categories % 95% CI 
Relationship to child Mother 95.0 94.3-95.8 
Caregiver 5.0 4.2-5.7 
Mean age of mother (Range) 25.3 (13-46) 
Infant gender Male 50.3 48.1-52.5 
Female 49.7 47.5-51.9 
Education of mother None 3.0 2.3-3.7 
Grade 1-7 17.9 15.7-20.2 
Grade 8-12 75.2 72.9-77.5 
Above Grade 12 2.1 1.3-2.9 
Marital status of mother Single 74.8 72.6-77.1 
Married/cohabitating 23.9 21.7-26.2 
Main building material of house Brick/Cement block 85.7 82.5-88.9 
98.6 97 
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Characteristics Categories % 95% CI 
Informal material 8.4 5.9-10.8 
Traditional material/mud 5.9 3.8-8.0 
Main source of drinking water 
  
Piped in house or yard 83.9 79.9-87.9 
Not piped in house or yard 16.1 12.1-20.1 
Type of toilet 
  
  
  
Flush toilet  30.3 23.9-36.7 
Pit latrine 66.5 60.1-72.8 
None 2.9 1.8-4.0 
Other 0.3 0.1-0.6 
Main source of fuel Electricity/Gas/Paraffin 88.3 65.6-77.2 
Other 11.7 22.8-34.4 
Depletion of food supply in past 12 
months 
Yes 8.9 6.6-11.2 
No 89.1 86.6-91.6 
 
Infant HIV Exposure and MTCT Rate in Mpumalanga  
Text Box 6 shows that infants’ HIV-exposure was 37.0%, with a 3.0% early infant HIV infection 
prevalence and a 5.7% (95%CI: 4.5-7.9%) MTCT rate at 4-8 weeks. This is the second highest MTCT 
among South African provinces. Among infants whose mothers reported being HIV-negative 7.8% 
(95%CI: 5.8-9.7) were HIV-exposed, the highest among South African provinces (along with Eastern 
Cape).  
 
Text Box 6: Mpumalanga HIV Infant Exposure and MTCT 
Infant HIV Exposure % 
(95%CI) 
Infant HIV infection 
prevalence at 4-8 
weeks 
MTCT @ 4-8 
weeks:%(95%CI) 
%Infants of reported 
HIV-negative mothers 
who had HIV antibody 
37.0 (34.3-39.7) 3.0 (2.1-3.8) 5.7 (4.1-7.3) 7.8 (5.8-9.7) 
 
PMTCT service uptake (PMTCT cascade) in the Mpumalanga 
Mpumalanga also had a high coverage of testing. (Figure 11) However the high rate of HIV-exposed 
infants whose mothers reported being HIV-negative suggests that these mothers and babies would 
not have received any ARV prophylaxis and this, coupled with the poor PMTCT cascade above (<70% 
mothers receiving CD4 cell count results; 83.6% receiving ARV prophylaxis or HAART and adherence 
to these regimens is not known i.e. ‘effective coverage’ is unknown) potentially explains the high 
MTCT rate in Mpumalanga province.  
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Figure 11  PMTCT service uptake (PMTCT cascade) in Mpumalanga 
 
Note: The first three indicators apply to all mothers, while the last three apply only to those who 
reported being HIV-positive. Red indicates the percentage receiving HAART while blue indicates the 
percentage receiving ARV prophylaxis.  
 
3.6.7 Northern Cape 
Northern Cape achieved a sample realisation of 63%.  This was due to a high number of medium-size 
clinics in the sample requiring disproportionate resources.  
General Description of Provincial Sample 
In Northern Cape 78.0% of mothers were single.  More than 80% of families had Brick/Cement 
house, piped water and flush toilets.  Only 10.9% reported depletion of food supply in the past 12 
months (Table 16) 
 
Table 16  Baseline characteristics of Northern Cape SAPMTCTE survey participants 
Characteristics Categories % 95% CI 
Relationship to child Mother 97.6 96.7-98.5 
Caregiver 2.4 1.5-3.3 
Mean age (range) 25.8 (14-45) 
Infant gender Male 48.9 46.1-51.7 
Female 51.1 48.3-53.9 
Education of mother None 3.5 2.6-4.4 
Grade 1-7 18.3 16.1-20.4 
Grade 8-12 74.3 71.8-76.9 
Above Grade 12 3.0 1.9-4.2 
Marital status of mother Single 78.0 75.0-81.1 
Married/cohabitating 21.1 18.0-24.1 
98.6 97.1 
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Characteristics Categories % 95% CI 
Main building material of house Brick/Cement block 80.4 77.5-83.4 
Informal material 18.7 15.9-21.5 
Traditional material/mud 0.9 0.4-1.3 
Main source of drinking water 
  
Piped in house or yard 93.5 91.6-95.4 
Not piped in house or yard 6.5 4.6-8.4 
Type of toilet 
  
  
  
Flush toilet  87.6 85.1-90.1 
Pit latrine 7.8 5.9-9.8 
None 2.2 1.4-3.0 
Other 2.4 1.7-3.0 
Main source of fuel Electricity/Gas/Paraffin 97.6 96.7-98.5 
Other 2.4 1.5-3.3 
Depletion of food supply in past 12 
months 
Yes 10.9 8.1-13.6 
No 89.1 86.4-91.9 
 
Infant HIV Exposure and MTCT Rate in the  Northern Cape 
Text Box 7 shows that infants’ HIV-exposure was 16.0%, with a 0.3% early infant HIV infection 
prevalence and a 1.4% (95%CI: 0.1-3.4%) MTCT rate at 4-8 weeks. The larger confidence interval 
attached to this estimate is due to the smaller sample size attained in Northern Cape.  
 
Text Box 7: Infant HIV Exposure and MTCT Rate Northern Cape 
Infant HIV Exposure % 
(95%CI) 
Infant HIV infection 
prevalence at 4-8 
weeks 
MTCT @ 4-8 
weeks:%(95%CI) 
%Infants of reported 
HIV-negative mothers 
who had HIV antibody 
16.0 (13.7-18.3) 0.3 (0.1-0.6) 1.4 (0.1-3.4) 2.2 (1.2-3.3) 
 
PMTCT service uptake (PMTCT cascade) in the Northern Cape 
Northern Cape has the lowest intended early infant diagnosis coverage of all provinces. Very few 
(1.6%) HI- positive mothers indicated an intention to receive infant testing service at the 6-week 
immunisation visit. However, the second highest CD4-cell count uptake is reported in the Northern 
Cape, at 88.7%.  Other PMTCT cascade indicators of the province have above 90% coverage, similar 
to other provinces. The rate of maternal potential HIV acquisition was 2.2% (upper limit 3.2%). The 
low MTCT rate is likely due to the high coverage of the PMTCT cascade in Northern Cape and the 
lower HIV acquisition rate compared with other provinces. 
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Figure 12  PMTCT service uptake (PMTCT cascade) in the Northern Cape 
 
Note: The first three indicators apply to all mothers, while the last three apply only to those who 
reported being HIV-positive. Red indicates the percentage receiving HAART while blue indicates the 
percentage receiving ARV prophylaxis.  
 
3.6.8 The North West Province 
 The SAPMTCTE in the North West province attained 98% of targeted sample size. 
General Description of Provincial Sample 
In North West province 83.1% of mothers were single.  Just over 70% of families had brick/cement 
houses and piped water, but fewer than half had a flush toilet (44.1).  Reported depletion of food 
supply in the last 12 months was 19.1%. 
 
Table 17 Baseline characteristics of North West SAPMTCTE survey participants 
Characteristics Categories % 95% CI 
Relationship to child Mother 97.0 96.1-97.9 
Caregiver 3.0 2.1-3.9 
Mean age (range) 26.3 (14-46) 
Infant gender Male 50.9 48.9-52.8 
Female 49.1 47.2-51.1 
Education of mother None 5.3 3.6-7.0 
Grade 1-7 19.1 16.1-22.0 
Grade 8-12 71.8 67.9-75.8 
Above Grade 12 3.3 2.2-4.4 
Marital status of mother Single 83.1 80.8-85.6 
Married/cohabitating 16.0 13.6-18.4 
Main building material of house Brick/Cement block 73.8 70.7-76.9 
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Characteristics Categories % 95% CI 
Informal material 24.0 21.1-26.9 
Traditional material/mud 2.2 1.2-3.1 
Main source of drinking water 
  
Piped in house or yard 75.9 71.3-80.4 
Not piped in house or yard 24.1 19.6-28.7 
Type of toilet 
  
  
  
Flush toilet  44.1 37.1-51.0 
Pit latrine 54.0 47.1-61.0 
None 1.3 0.8-1.9 
Other 0.6 0.1-1.0 
Main source of fuel Electricity/Gas/Paraffin 93.5 91.4-95.5 
Other 6.5 4.5-8.6 
Depletion of food supply in past 12 
months 
Yes 19.1 16.4-21.7 
No 80.6 78.0-83.3 
 
Infant HIV Exposure and MTCT Rate in North West Province 
Text Box 8 shows that infants’ HIV-exposure was 31.3%, with a 1.9% early infant HIV infection 
prevalence and a 4.4 (95% CI 2.9-5.9%) MTCT rate at 4-8 weeks. Of infants whose mothers reported 
being HIV-negative 5.4% (95% CI 3.9-6.8%) were HIV-exposed.  
 
Text Box 8: Infant HIV Exposure and MTCT Rate in North West Province 
Infant HIV Exposure % 
(95%CI) 
Infant HIV infection 
prevalence at 4-8 
weeks 
MTCT @ 4-8 
weeks:%(95%CI) 
% Infants of reported 
HIV-negative mothers 
who had HIV antibody 
31.3 (29.0-33.5) 1.9 (1.2-2.5) 4.4 (2.9-5.9) 5.4 (3.9-6.8) 
 
PMTCT Service Uptake (PMTCT cascade) in the North West Province 
North West study participants had close to 100% HIV testing rate,  but lower coverage of CD4 count 
(81.7%) and EID  services.  The province ranked as the second lowest in intended EID coverage.  Only 
3.6% of HIV-positive mothers in the sample intended to receive EID at the time of immunisation visit. 
The higher rate of infants with reported HIV-negative mothers who were HIV-exposed and who 
would not have received any PMTCT interventions, coupled with a only a 91.1% coverage of ARV 
prophylaxis / HAART may explain the somewhat higher MTCT rate measured in the North West 
province. 
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Figure 13 PMTCT service uptake (PMTCT cascade) in the North West Province 
 
Note: The first three indicators apply to all mothers, while the last three apply only to those who 
reported being HIV-positive. Red indicates the percentage receiving HAART while blue indicates the 
percentage receiving ARV prophylaxis.  
 
3.6.9 Western Cape 
The SAPMTCTE in the Western Cape attained 99% of targeted sample size. 
General Description of Provincial Sample 
The majority of Western Cape participants reported use of piped water (in house) (93.9%), flush 
toilet (90.7%) and electricity, gas or paraffin (99.3%) for their fuel needs. However, a substantial 
percentage (31.1%) of the participants reported living in a house built from informal materials. A 
large percentage (26.1%) of respondents also reported that they experienced food shortage at least 
once in the last 12 months.   
 
Table 18  Baseline characteristics of Western Cape SAPMTCTE survey participants 
Characteristics Categories % 95% CI 
Relationship to child Mother 97.1 96.3-97.9 
Caregiver 2.9 2.1-3.7 
Mean age (range) 26.4 (14-47) 
Infant gender Male 49.7 47.4-52.0 
Female 50.3 48.0-52.6 
Education of mother None 0.8 0.3-1.3 
Grade 1-7 15.1 12.2-17.9 
Grade 8-12 76.2 73.0-79.4 
Above Grade 12 7.3 5.1-9.5 
Marital status of mother Single 54.3 50.5-58.1 
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Characteristics Categories % 95% CI 
Married/cohabitating 44.0 40.2-47.8 
Main building material of house Brick/Cement block 68.5 63.3-73.7 
Informal material 31.1 26.0-36.3 
Traditional material/mud 0.4 0.1-0.6 
Main source of drinking water 
  
Piped in house or yard 93.9 91.9-95.8 
Not piped in house or yard 6.1 4.2-8.0 
Type of toilet 
  
  
  
Flush toilet  90.7 88.4-93.0 
Pit latrine 5.6 3.5-7.7 
None 1.3 0.6-2.0 
Other 2.4 1.5-3.3 
Main source of fuel Electricity/Gas/Paraffin 99.3 99.0-99.7 
Other 0.7 0.3-1.0 
Depletion of food supply in past 12 
months 
Yes 26.1 22.9-29.2 
No 73.0 69.9-76.0 
 
Infant HIV Exposure and MTCT Rate in Western Cape 
Text Box 9 shows that infants’ HIV-exposure was 21.0%, with a 0.9% early infant HIV infection 
prevalence and a 3.9% (95% CI 1.9-5.8%) MTCT rate at 4-8 weeks. The percent of HIV-exposed 
infants whose mothers reported being HIV-negative was the lowest in the Western Cape at 1.1%. 
 
Text Box 9: Infant HIV Exposure and MTCT Rate in Western Cape 
Infant HIV Exposure % 
(95%CI) 
Infant HIV infection 
prevalence at 4-8 
weeks 
MTCT @ 4-8 
weeks:%(95%CI) 
%Infants of reported 
HIV-negative mothers 
who had HIV antibody 
21.0 (30.7-33.3) 0.9 (0.4-1.5) 3.9 (1.9-5.8) 1.1 (0.3-1.9) 
 
PMTCT service uptake (PMTCT cascade) in the Western Cape 
The Western Cape had close to 100% (98.8%) antenatal HIV testing rate. Almost all (98.7%) mothers 
who had antenatal HIV testing received their result. About 94.2% of the HIV-positive mothers were 
on either HAART or ARV prophylaxis (including infant prophylaxis if mother is not on HAART). Similar 
to other provinces, the majority of the mothers did not plan to receive EID services during the six-
week immunisation visit.  
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Figure 14   PMTCT service uptake (PMTCT cascade) in the Western Cape Province 
 
Note: The first three indicators apply to all mothers, while the last three apply only to those who 
reported being HIV-positive. Red indicates the percentage receiving HAART while blue indicates the 
percentage receiving ARV prophylaxis.  
 
3.7 Infant Feeding  
HIV-positive mothers who recalled receiving infant feeding counselling during antenatal care was 
89.2% with a range from 77.9% in Limpopo to 92.4% in Gauteng and KwaZulu-Natal. 
 
Among all infants (regardless of HIV exposure status) 44.8% (95% CI 43.23-46.3%) were mixed 
breastfeeding; 28.0% (95% CI 25.6-29.4%) were exclusively breastfed in the 8 days prior to the 4-8 
week interview and 27.2% (95% CI 26.1-28.3%) received no breast milk. 
  
We categorised HIV-exposed infants who received breast milk plus any other milk or food (not 
including prescribed medicines) over the past eight days as being at-risk as they were practicing 
mixed breastfeeding.  This ranged from a low of 7.0% in the Western Cape to a high of 32.8% in 
Limpopo, with a national average of 18.1% (Table 19).  It is interesting to note that the province with 
the lowest rate of infant feeding counselling had high rates of at risk infant feeding in HIV-exposed 
infants. 
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Table 19 Infant feeding practices amongst HIV exposed infants over the past 8 days by province 
Province 
Mother reportedly 
received infant feeding counseling 
during ANC % (95% CI) 
At Risk/ Mixed Feeding 
% (95% CI) 
Eastern Cape  82.4 (76.1-88.8) 20.3 (16.6-23.9) 
Free State  91.6 (88.7-94.6) 22.9 (19.1-26.8) 
Gauteng  92.4 (89.7-95.1) 14.8 (11.4-18.1) 
KwaZulu-Natal  92.4 (90.0-94.8) 14.0 (10.5-17.5) 
Limpopo  77.9 (72.0-83.7) 32.8 (27.0-38.7) 
Mpumalanga  91.5 (88.4-94.6) 29.7 (26.0-33.4) 
Northern Cape  81.0 (73.3-88.6) 23.9 (16.1-31.8) 
North West  81.5 (76.1-86.8) 21.3 (17.5-25.1) 
Western Cape  85.3 (80.5-90.1) 7.0 (4.3-9.6) 
South Africa  89.2 (87.8-90.6) 18.1 (16.5-19.7) 
   
Among mothers of HIV-exposed infants 20.4% (95% CI 18.5-22.3%) were practicing exclusive breast 
feeding (EBF), 61.5 (59.2-63.8) formula feeding (no breast milk) and 18.1% (95% CI 16.5-19.7%) 
mixed breast feeding in the eight days prior to the interview. Among non-breastfed HIV-exposed 
infants, none were exclusively formula fed (i.e., non-breastfed infants were always given something 
else such as water, traditional medicines or solids).   
 
Comparing feeding rates in HIV-exposed infants across provinces shows most provinces falling in the 
national average except Northern Cape and Western Cape.  The Northern Cape had the highest rate 
of exclusive breast feeding rate (43.7%; 95% CI 37.0-50.3) and the lowest formula feeding (no breast 
milk) (32.4%; 95% CI 26.3-38.5), while the Western Cape had the lowest EBF rate of only 7.9% (95% 
CI 5.3-10.4) and the highest formula feeding at 85.1% (95% CI 81.3-89.0). It should be noted that ‘no 
breastmilk’ does not imply formula feeding only without other fluids or foods as highlighted above. 
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4. DISCUSSION 
4.1 Infant HIV Exposure 
Figure 15 indicates the 2010 maternal HIV prevalence in mothers from the antenatal sentinel 
surveillance by province (NDOH, 2011).  There is close agreement with the SAPMTCTE provincial 
level estimates of presumed maternal HIV prevalence based on HIV antibody found in infant DBS.   
 
The national rate for the SAPMTCTE was 32.0% with a 95% confidence interval of 30.7-33.3%, which 
is consistent with the ANC sentinel surveillance estimate of 30.2% (95% CI 29.4-30.9) from 2010.  As 
would be expected the SAPMTCTE result is slightly higher as it is taken 6 weeks postnatal rather than 
early pregnancy considering that some women will seroconvert during pregnancy.  The similarity 
between the SAPMTCTE and the ANC Sentinel Surveillance data lend strong validity to the 
SAPMTCTE results as they are consistent with national and provincial representative maternal HIV 
prevalence estimates. 
 
Figure 15  Maternal antenatal HIV prevalence by province in South Africa 
 
4.2 Mother-to-Child Transmission of HIV 
Figure 16 presents data from the National Health Laboratory Service (NHLS) DNA PCR data 
warehouse (Personal Communication, Prof. Gayle Sherman, 2011) for infants less than 2 months old.  
These estimates do not include KwaZulu-Natal nor do they include secondary and tertiary hospital 
data.  Nevertheless the results are similar to the SAPMTCTE data and indicate a sharply decreasing 
trend in MTCT in the past three years which is very encouraging.  Additional analysis of NHLS data 
including data from KwaZulu-Natal, and restricting data to quarters 3 and 4 of 2010 (same time 
period as this survey) suggest positive DNA PCR rates of 3.5% which further declines to 3.2% when 
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only primary health care facilities are considered.  SAPMTCTE 4-8 week results are therefore 
consistent with NHLS routine data. While these different data sources have varying methods, 
limitations and strengths the underlying message is that MTCT has reduced substantially in South 
Africa over the past three years and at present is less than 5%. 
  
Figure 16  NHLS Early Infant Diagnosis PCR <2 months old 2008-2010 (from Sherman, 2010) 
 
 
The MTCT rate measured at six weeks in recent PMTCT studies (not operational settings) using 
somewhat similar regimens to the South African 2010 PMTCT policy include:  
 SWEN (2008) - Sd NVP peripartum and daily in infant until 6 weeks; 2.5% MTCT at 6 weeks;  
 Mitra (Kilewo et.al., 2008) -ZDV/3TC peripartum and 3TC postnatally; MTCT 3.8% at 6 
weeks); and  
 Kesho Bora (2011) - AZT/NVP in mothers vs. HAART for mothers; MTCT 5.0% versus 3.3% 
respectively at 6 weeks). 
 
The SAPMTCTE results compare favourably with these results. Achievement of results similar to trials 
in a national PMTCT programme is very encouraging. 
 
Provincial Variation in MTCT 
There was a greater than 4-fold difference in MTCT across the 9 provinces in South Africa, ranging 
from 1.4 in Northern Cape to 5.9 in the Free State. The provincial variation in MTCT is probably due 
to the differences in ‘effective coverage’ and quality of the PMTCT programme including uptake of 
C4 cell count testing results, repeat HIV testing at 32 weeks, appropriate ARV prophylaxis/HAART for 
HIV-positive women, and adherence to PMTCT regimens.  More detailed explorations of quality and 
adherence to PMTCT prophylaxis or HAART is needed to understand MTCT rates in some of the 
provinces such as Free State. 
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Maternal potential HIV acquisition also varies across provinces and somewhat mirrors MTCT rates.  
Mothers who report being HIV-negative but are in fact HIV-positive are at higher risk of transmission 
as they would not have accessed ARV therapy in the perinatal period and if they actually acquired a 
new infection during pregnancy they are at particularly high risk of transmission.  
  
4.3 PMTCT Cascade 
Missed opportunities along the PMTCT cascade of services (Stringer et.al., 2003) can reduce both the 
coverage and quality of the PMTCT programme.  HIV Testing in ANC clinics is the entry point into the 
PMTCT programme.  High coverage of this and each subsequent step reduces missed opportunities 
for care.  In this study, ANC HIV testing and receipt of results by mothers were almost universal 
98.8% but services further along the cascade were not as high, with only 78.3% of HIV-positive 
mothers getting a CD4 count. A percentage of 91.8% of mothers and infants received ARV 
prophylaxis or treatment according to protocol.  However, this data does show improvement over a 
previous report from KwaZulu-Natal where prior to a quality improvement intervention only 85% of 
women were tested in ANC, 40% received a CD4 test and only 15% were given appropriate ARV 
prophylaxis (Doherty et.al., 2009).  After the intervention, the data from the Doherty study was 
comparable to the SAPMTCTE with 98% ANC HIV testing, 97% CD4 testing and 68% appropriate ARV 
prophylaxis.  There has been an effort in South Africa in the last few years to improve the PMTCT 
programme through interventions like the one described by Doherty et.al. (2009) as well as others 
(e.g. Best Practices in Prevention of Mother-to-Child Transmission (PMTCT) of HIV South Africa; 
NDOH/MRC/UWC/UNICEF/USAID, 2009).  These efforts are clearly impacting PMTCT, as shown by 
programme indicators and infant outcomes (early MTCT) as described in this report.  
 
Of ALL mothers enrolled in the survey, 29.4% reported being HIV-positive while HIV antibody was 
found in 32% of ALL infants. Of concern is that of those mothers who reported being HIV negative, 
4.1% of their infants had HIV antibodies, suggesting a high rate of maternal potential acquisition of 
HIV infection during pregnancy.  This rate also varied substantially across provinces from a low of 
1.1% in the Western Cape to a high of 7.8% in Mpumalanga and Eastern Cape. The indicator 
‘Maternal potential HIV acquisition’ is a combination of the following scenarios:   
(i) Mothers do not wish to admit being HIV-positive and reported being HIV negative. The 
2010 data show that refusals for infant HIV testing were low and disclosure was high; 
thus the contribution that this scenario makes to the indicator is probably minimal.   
(ii)  Mothers were tested during the window period.  
(iii)  Poor QC/performance of rapid tests in the field caused false negative results at ANC on 
HIV-infected women. Reported field sensitivities are as low as 87% to 95% depending on 
the rapid test. 
(iv)  True acquisition of HIV after the last HIV test – which for most mothers was during 
pregnancy. 
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Regardless of the cause this group of women and infants represent a substantial missed opportunity 
for care as the mothers and infants did not receive ARV prophylaxis or appropriate counselling.  The 
high rate of maternal potential HIV acquisition is also worrying as it is higher than previously 
reported (3%) in a study conducted in KwaZulu-Natal (Moodley et al., 2009).  
 
4.4 Early Infant Diagnosis 
Intention to obtain a PCR test for their infant in reported HIV-positive mothers is only just above 
one-third.  This low figure is very concerning.  While Provider Initiated Testing and Counseling (PITC) 
in the six week immunisation clinic should note infant’s HIV-exposure on the Road-to-Health Card 
and offer infant PCR testing, the NHLS data, Figure 16 suggests recent coverage is only just above 
half of what would be expected.  This study could not measure EID rates as the study tested all 
infants present in a clinic and took the place of the routine EID programme during the period of the 
study in each clinic.  However, low intention by mothers to obtain early infant HIV testing combined 
with other missed opportunities along the PMTCT cascade noted in this report and the low reported 
coverage by NHLS suggest that universal offer of testing (PITC) for all infants at 6 weeks of age, 
linked with the six-week immunisations, may reduce missed opportunities to identify HIV-positive 
infants in need of ARV therapy.  
4.5 Infant Feeding 
Infant feeding per caregiver recall for the past 8 days suggests substantial mixed breastfeeding 
regardless of HIV status of the mother.  This is very consistent with other sources of data for South 
Africa (NDOH/MRC, 2003; Tylleskar et al., 2011) and is of great concern. Poor infant feeding can be 
expected to result in higher postnatal transmission of HIV after the 4-8 weeks of age and increased 
infant morbidity and mortality.  So while the decrease in MTCT seen in the 4-8 week period is very 
encouraging, these gains could be negated through poor infant feeding and postnatal transmission.  
Infant feeding needs to be urgently addressed and postnatal transmission and HIV-free survival 
urgently need to me measured and monitored in order to track progress to meet national strategic 
goals of less than 5% MTCT overall.  Improved infant feeding counselling should assist with this goal.  
It was very interesting to note, in our data, that the Limpopo province which had the lowest 
reported infant feeding counseling for HIV-positive mothers also had the highest rate of mixed/at-
risk infant feeding.  
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5. STRENGTHS AND LIMITATIONS OF SAPMTCTE  
Strengths 
This evaluation provides estimates using a national and provincial population-based representative 
sample of infants 4-8 weeks of age.  It also provides data on indicators of the PMTCT programme and 
potential maternal sero-conversion during pregnancy.   
Limitations 
The following limitations are found in this survey: 
 
The data is facility-based using infants presenting for immunisation.  Infants who do not come for 
immunisation or have already died by 6 weeks of age are not included in the sample suggesting a 
possible under-estimation of infant HIV infection prevalence. 
 
Maternal Incidence (sero-conversion during pregnancy) was based on self-reports of previous HIV-
negative status and presence of HIV antibodies in infant ELISA test.  Mothers may not accurately 
report their previous HIV status for a variety of reasons, such as fear of stigma and disclosure.  
Confidentiality was assured and discussed as part of the informed consent process and a private 
place was secured for the conduct of interviews in an attempt to reduce this potential limitation.  
 
Coverage of PMTCT programme indicators was via maternal recall and was not verified with 
maternal antenatal or intrapartum records, however the recall period was relatively short (generally 
less than 3-6 months).  
 
Two-stage cluster random sampling was used.  The primary sampling unit was primary health care 
clinics reporting at least 130 immunisations per year from the 2007 DHIS data.  Therefore this 
sample excluded smaller primary health care facilities due to logistic reasons and secondary and 
tertiary facilities, mobile clinics and other facilities in order to focus on PMTCT in the primary health 
care services.  Therefore this survey is not representative of these excluded facilities. 
 
Finally, this survey was conducted from June to December 2010.  The new PMTCT guidelines were 
introduced in April 2010 so most facilities would likely have been in transition to the new guidelines 
during the period of the study.  This survey was not meant to measure efficacy of any particular 
protocol or PMTCT ARV regimen but only to evaluate the performance of the overall PMTCT 
programme as implemented during the time of the study using MTCT at 6 weeks of infant age as the 
outcome measure.  Also since the survey outcome is at 6 weeks of infant age, postnatal transmission 
of HIV is not measured in this study.  
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6. CONCLUSION AND RECOMMENDATIONS 
 
Based on the 2010 SAPMTCT evaluation (the first national evaluation of the PMTCT programme in 
South Africa), the National PMTCT programme resulted in 3.5% national MTCT rate in pregnancy and 
intrapartum. A reduction is noted from the approximately 30% transmission that would occur during 
pregnancy, labour and delivery in the absence of PMTCT interventions. A decreasing trend in MTCT 
is also shown by the NHLS data. This could contribute towards a reduction in HIV-incident infection 
at a population level and to virtual paediatric HIV elimination, providing postnatal PMTCT 
interventions are intensified. 
 
The approximately greater than four-fold difference in MTCT rate across provinces (1.4% to 5.9%) is 
likely due to the differences in the quality of the PMTCT programme across provinces, including 
different PMTCT coverage of ARV prophylaxis and HAART, and substantial differences in HIV-
exposed infants whose mothers reported being HIV-negative as these infants are potentially as 
highest risk and did not benefit from appropriate ARV prophylaxis.  
 
Maternal potential HIV acquisition during pregnancy was potentially high at 4%, necessitating an 
intensification of the policy of repeat testing at 32 weeks and implementation of couple testing to 
identify discordant couples and counsel them about HIV prevention. Further data should to be 
collected to assess the contribution of false negative rapid test results to maternal potential HIV 
acquisition and work is needed to improve the quality of rapid HIV testing in the field. 
    
Infant HIV test uptake was high if offered to all caregivers bringing their infants for six week 
immunisation (92% in the SAPMTCT survey versus 55% who come for HIV testing and are captured 
by NHLS data). The high acceptance of infant HIV testing among SAPMTCTE participants highlights 
the need to review infant HIV testing strategies so that provider-initiated early infant testing is 
offered at all six-week immunisation visits and at all child health service delivery points. This will 
increase EID coverage and provide PMTCT to unknown HIV-exposed infant 
 
The poor feeding practices during the first 6 weeks postpartum highlights the need to strengthen 
infant feeding counselling, adherence to postnatal prophylaxis and to monitor MTCT and HIV- free 
survival from 6 weeks to 18 months and HIV-free survival beyond six weeks. 
 
Although the data suggests a greater than 80% reduction in MTCT from 25% - 30% (no PMTCT 
interventions) to 3.5%, virtual paediatric HIV elimination will only be possible with intensified efforts 
and a change in approach towards infant feeding. Estimated targets to reach the 2015 South African 
national targets would be MTCT rates of less than 2% at 6 weeks and less than 5% at 18 months 
(WHO/UNICEF/UNFPA/UNAIDS, 2011). Gaps in effective PMTCT coverage for all steps in the PMTCT 
cascade need to be addressed, and postnatal MTCT must be prevented through improved infant 
feeding and expanded coverage of the postnatal prophylaxis programme.  
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Further work by the SAPMTCTE Study Group supported by the National Department of Health will be 
conducted in 2011 and 2012 to track progress with MTCT reduction at six weeks and to track 
progress with MTCT reduction between six weeks and 18 months. 
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APPENDIX I: SAMPLE SIZE AND SAMPLING 
 
 
(See next page)
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SAMPLE SIZE CALCULATION BY PROVINCE 
 
  Antenatal 
HIV 
Prevalence 
2007 
% 
antenatal 
HIV test 
(%) 
% 
admin 
of 
PMTCT 
to 
babies 
Estimated 
Coverage 
(prevalence 
X %tested X 
%admin to 
baby) 
Est. not 
Covered 
Transmission 
Rate in 
exposed 
assuming SD 
NVP 
MTCT=15% & 
untreated 
MTCT=29% 
(Rollins)* 
Overall 
Population 
Prevalence 
per 100 kids 
Same 
precision 
across 
province 
Same 
relative 
precision 
across 
province 
(%) 
sample 
size for 
30% 
relative 
precision 
Sample 
size for 
design 
effect** 
of  2 & 
relative 
precision 
30% 
Overall 
population 
prevalence 
per 100 
kids (%) 
Varying 
precisio
n by 
province 
Varying 
relative 
precisio
n by 
province 
(%) 
Sample 
size 
using 
varying 
precisio
n level  
without 
design 
effect 
Sample 
size 
using 
varying 
precisio
n level  
with 
design 
effect**    
of 2 
SA 29 67 47 31.5% 68.5% 24.6% 7.1% 2.1 30 575 1150      
                  
WC* 15 97 75 72.8% 27.3% 13.0% 1.9% 0.6 30 1989 3978 1.9 1.0 51 716 1400 
NC 14 81 70 56.7% 43.3% 21.1% 2.9% 0.9 30 1336 2672 2.9 1.8 60 350 700 
EC 24 73 35 25.6% 74.5% 25.4% 6.1% 1.8 30 680 1360 6.1 1.8 30 700 1400 
FS 29 70 52 36.4% 63.6% 23.9% 6.9% 2.1 30 560 1120 6.9 2.0 29 617 1300 
KZN 37 66 52 34.3% 65.7% 21.4% 7.9% 2.4 30 485 970 7.9 2.0 25 699 1400 
MP 34 56 36 20.2% 79.8% 26.2% 8.9% 2.7 30 428 856 8.9 2.0 22 779 1600 
LP 20 74 54 40.0% 60.0% 23.4% 4.7% 1.4 30 878 1756 4.7 1.5 32 703 1400 
NW 29.9 86 50 43.0% 57.0% 23.0% 6.9% 2.1 30 560 1119 6.9 2.0 29 601 1200 
GP 31 65 27 17.6% 82.5% 26.5% 8.2% 2.5 30 463 926 8.2 2.0 24 723 1800 
Total          7379 14758     12200 
 ANC Prevalence & Coverage Data 
from DHIS  
  *WC & KZN assume full coverage dual therapy - Rollins KZN Study is 7%      
      ** Design Effect = 1+(100-1)*(ICC=.01)=2          
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SAMPLING  
 
Table 3 - number of facilities needed to be sampled from each province to collect data within 3wks (4 weeks for Northern Cape) duration from each facility. 
Note DTP1 = 1st DTP 
 
WESTERN CAPE 
Strata 
Total Annual 
DTPDTP# 
Percentage 
Sample Size 
Proportional 
Median Yearly 
Clinic DTP1 
Number 
Media 3-week 
Clinic DTP1 
Number 
Number of 
Facilities to be 
Visited 
Small clinics (< 130 
DTPDTP1#) 
4537     20 
Medium size clinics (130-300 
annual DTPDTP1#) 
15953 17.85 250 192 11 23 
 
Large size (annual DTPDTP1 
#>300) but low prev clinics 
62884 70.38 985 535 31 32 
Large size (annual DTPDTP1 
#>300) but high prev clinics 
10517 11.77 165 857 49 3 
Overall Total 89354 100 1400   58 (or 78 if small 
facilities are 
included) 
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EASTERN CAPE  
 
Strata 
Total 
Annual 
DTPDTP for 
the 
province 
Percentage 
Adjusted 
Percentage 
Sample size 
proportional 
Sample size 
adjusted 
proportional 
Median  
yearly clinic 
DTP1 
number 
Median 3 
week clinic 
DTP1 
number 
number of 
facilities 
need to be 
visited 
Number of 
facilities 
that should 
be visited 
based on 
adjusted 
distribution 
Small clinics (<130 
DTPDTP1#) 
25862       20 20 
Medium size clinics  
(130-300 annual DTP1#) 
41620 36.38 30 509 420 186.5 11 47 39 
large size (Annual DTP1 
#>300) but low prev 
clinics 
41646 36.40 43 510 602 459 26 19 23 
large size (Annual DTP1 
#>300) but high prev 
clinics 
31141 27 27 381 378 402 23 16 16 
Overall Total 114407 100 100 1400 1400   83 78 (or 98 if 
small 
facilities are 
included) 
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FREE STATE 
 
Strata 
Total Annual DTP 
for the province 
Percentage 
Sample size 
proportional 
Median  yearly 
clinic DTP1 
number 
Median 3 week 
clinic DTP1 
number 
number of 
facilities need to 
be visited 
Small clinics (<130 
DTP1#) 
4880     20 
Medium size clinics  
(130-300 annual 
DTP1#) 
14418 27.34% 355 201 12 31 
large size (Annual 
DTP1 #>300) but 
high prev clinics 
38326 72.66% 945 404 23 41 
Overall Total 52744 100% 1300   72 (or 92 if small 
facilities are 
included) 
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GAUTENG 
Strata 
Total Annual 
DTP for the 
province 
Percentage 
Sample size 
proportional 
Median  yearly 
clinic DTP1 
number 
Median 3 
week clinic 
DTP1 number 
number of 
facilities need 
to be visited 
Small clinics (<130 DTP1#) 1926     20 
Medium size clinics  (130-300 annual 
DTP1#) 
15359 8.95% 161 237.5 14 12 
Large size (Annual DTP1 #>300) but 
low prev clinics 
33023 19.25% 347 549 32 11 
Large size (Annual DTP1 #>300) but 
high prev clinics 
123199 71.80% 1292 629 36 36 
Overall Total 171581 100% 1800   
59 (or 79 if small 
facilities are 
included) 
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KWAZULU-NATAL 
Strata 
Total Annual 
DTP for the 
province 
Percentage 
Sample size 
proportional 
Median  yearly 
clinic DTP1 number 
Median 3 week 
clinic DTP1 
number 
number of facilities 
need to be visited 
Small clinics (<130 DTP1#) 7365     20 
Medium size clinics  (130-300 
annual DTP1#) 40070 20.84% 292 209 12 24 
large size (Annual DTP1 
#>300) but low prev clinics 6505 3.38% 47 536.5 31 2 
large size (Annual DTP1 
#>300) but high prev clinics 145661 75.77% 1061 483 28 38 
Over all Total 192236 100% 1400   
64 (or 84 if small 
facilities are included) 
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LIMPOPO 
 
 
 
 
 
       
Strata 
Total Annual DTP 
for the province 
Percentage 
Sample size 
proportional 
Median  yearly 
clinic DTP1 
number 
Median 3 week 
clinic DTP1 
number 
number of 
facilities need to 
be visited 
Small clinics (<130 
DTP1#) 
7166     20 
Medium size clinics  
(130-300 annual 
DTP1#) 
41027 33.89% 474 206 12 40 
large size (Annual 
DTP1 #>300) but low 
prev clinics 
80048 66.11% 926 470.5 27 34 
large size (Annual 
DTP1 #>300) but high 
prev clinics 
0 0.00% 0  0 0 
Over all Total 121075 100% 1400   
74 (or 94 if small 
facilities are 
included) 
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MPUMALANGA 
 
Strata 
Total 
Annual 
DTP for 
the 
province 
Percentage 
Adjusted 
percentage 
Sample size 
proportional 
Sample size 
adjusted 
proportional 
Median  
yearly 
clinic 
DTPDTP1 
number 
Median 3 
week clinic 
DTPDTP1 
number 
number 
of 
facilities 
need to 
be 
visited 
number of 
facilities need 
to be visited 
based on 
adjusted 
distribution 
Small clinics 
(<130 DTP1#) 
4545            20   
Medium size 
clinics  (130-300 
annual DTP1#) 
20858 26.73% 20% 428 320 225 13 33 25 
 large size 
(Annual DTP1 
#>300) but low 
prev clinics 
0 0.00%   0 0 0 0 0 0 
 large size 
(Annual DTP1 
#>300) but high 
prev clinics 
57172 73.27% 80% 1172 1280 439 25 46 51 
Overall Total   78030 100% 100% 1600 1600    79 76 
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NORTHERN CAPE 
Strata 
Total Annual 
DTP for the 
province 
Percentage 
Sample size 
proportional 
Median  yearly 
clinic DTP1 
number 
Median 4 week 
clinic DTP1 
number 
number of 
facilities need 
to be visited 
Small clinics (<130 DTP1#) 2475     20 
Medium size clinics  (130-300 
annual DTP1#) 
7766 51.82% 363 207.5 16 23 
large size (Annual DTP1 
#>300) but low prev clinics 
7221 48.18% 337 400 32 11 
large size (Annual DTP1 
#>300) but high prev clinics 
0 0.00% 0  0  
Overall Total 14987 100% 700   
34 (or 54 if small 
facilities are 
included) 
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NORTH WEST 
Strata 
Total Annual 
DTP for the 
province 
Percentage 
Sample size 
proportional 
Median  yearly 
clinic DTP1 
number 
Median 3 week 
clinic DTP1 
number 
number of 
facilities need 
to be visited 
Small clinics (<130 DTP1#) 8758     20 
Medium size clinics  (130-
300 annual DTP1#) 
22925 34.26% 411 204.5 12 35 
large size (Annual DTP1 
#>300) but low prev clinics 
24100 36.02% 432 413 24 18 
large size (Annual DTP1 
#>300) but high prev clinics 
19887 29.72% 357 432.5 25 14 
Over all Total 66912 100% 1200   
67 (or 87 if small 
facilities are 
included) 
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Each province was divided into three strata: 
 Stratum 1 includes clinics and CHCs that have annual Dtp1st dose 130-300 based on the 
2007 DHIS data.  
 Stratum 2 includes clinics & CHCs with 300 and above Dtp1st dose & HIV prevalence below 
the national (<29%) rate based on the 2007 DHIS and 2008 antenatal survey data 
respectively. 
 Stratum 3 includes clinics & CHCs  with 300 & above Dtp1st dose (based on the 2007 DHIS 
data) &  HIV prevalence above  the national rate based on the 2007 DHIS data &  2008 
antenatal survey data respectively. 
 
In the small facilities stratum, 20 facilities were selected for situational analysis. Out of these 20 
facilities only 10 were selected based on the feedback from the situational analysis. 
 
Provinces that do not have the third stratum  
Western Cape, Limpopo and Northern Cape do not have a third stratum: there is no district with 
>29% HIV prevalence and high delivery rate (>300 immunisation) in these provinces. However, for 
Western Cape, we had a sub-district level data from the ANC survey, which indicated that 
Khayelitsha sub-district has more than 29% HIV prevalence. So, the third stratum was created from 
large clinics in Khayelitsha. We were not able to do the same for Limpopo and Northern Cape, as we 
did not have sub-district level HIV prevalence data (from the ANC survey) for the two provinces. 
Reduced sample size for Northern Cape  to 700 
There were 96 facilities that could be sampled in the Northern Cape; but logistically 96 clinics was 
not an achievable target within the allocated time. Consequently the researchers reduced the 
number of facilities that needed to be visited to 53.  
Adjusting weighting for Mpumalanga and Eastern Cape 
The number of facilities needed to be sampled for Mpumalanga and Eastern Cape was 79 and 83 
respectively.  In addition, most of the facilities were from medium sized clinics.  As this might be 
difficult to achieve with available logistics capacity, we slightly shifted the weighting to the large 
clinics (see column D), hence the number of facilities needed to be sampled from medium facilities 
decreased from 47 to 39  for the Eastern Cape and from33 to 25  for Mpumalanga (see column J). 
This was logistically feasible.  
 
In Free state, we had only two strata - we grouped the last two strata  as one stratum.  
The second strata (large and low HIV prevalence clinics) in Free state had only 0.74% weighting 
which translates to sampling  only 1 facility from the second stratum.  Since sampling cannot be 
done for one facility, the second stratum is combined with the third stratum  thus we have only two 
strata for Free state.  
Evaluation of thE EffEctivEnEss of thE 
national PrEvEntion of MothEr-to-child transMission (PMtct) 
PrograMME on infant hiv  MEasurEd at six WEEks 
PostPartuM in south africa
